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In order to optimize productivity of a cell culture it is necessary to understand growth and productivity 
and couple these features of the culture to extracellular nutrients whose profiles can be manipulated. Also, 
since growth and productivity are directly affected by cell death mechanisms such as apoptosis, it is 
imperative to understand these mechanisms. This work describes the development of a differential 
equation based population balance model of apoptosis in a Chinese Hamster Ovary cell culture producing 
Anti-RhD monoclonal antibody (mAb). The model was verified in isolation and was then coupled to a 
metabolic flux model. The model distinguishes between various subpopulations at normal healthy states 
and at various stages of apoptosis. After finding that glucose and glutamine are not limiting nutrients for 
this culture, different hypotheses were explored to explain growth arrest. Initially, it was hypothesized 
that there is some unknown nutrient in either media or serum which is depleted, thus causing growth 
arrest. Accordingly a first model was developed assuming depletion of this nutrient. Subsequent 
experiments with different additions of media and serum showed that there is no such nutrient limitation 
for the media and serum conditions used in most of the experiments. Additional experiments with 
different culture volumes showed that cell growth was actually controlled by a compound that 
accumulates and causes pH deviation from its optimal range of operation. Since strong correlations were 
found between culture volume and growth, it was hypothesized that the compound may be carbon dioxide 
(CO2), which is inhibitory for growth and may accumulate due to mass transfer limitations. Following this 
finding, a second model was proposed to take into account the accumulation of this inhibitor, although the 
specific inhibiting compound could not be exactly identified. This second mathematical model of cell 
growth was then integrated with a metabolic flux model to provide for a link between intracellular and 
extracellular species balances, since the latter are the ones to be manipulated for increasing productivity. 
This final model formulation was then used to describe mAb productivity. The model was also able to 
reasonably predict all cell subpopulations, nutrients, metabolites and mAb. In an attempt to mitigate the 
effect of CO2 accumulation and renew the cell growth, culture perfusions were performed. Although this 
approach resulted in some renewal of growth, the cell concentration progressively decreased after each 
successive perfusion event. This suggests that irreversible cell damage occurs because of CO2 
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accumulation. The model was used to describe the perfusion experiments. Agreement between data and 
model predictions were reasonable. In addition, it was shown that operation with successive perfusions 
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Chapter 1  
Introduction 
This thesis is concerned with modeling apoptosis in cell culture, specifically addressing interactions 
between apoptosis and cell growth. The work is aimed at providing a deeper understanding of cell culture 
process for optimization of product yield. The work incorporates measurements of various caspases 
(apoptotic proteins) in culture by flow cytometry. The work investigates cell-cell interaction that triggers 
apoptosis and develops a comprehensive model of apoptosis, metabolic flux and monoclonal antibody 
production. This chapter motivates the research discussed in the thesis, beginning with an overview of 
cell culture technology, and discusses existing efforts towards modeling cell culture processes. 
1.1 Mammalian cell culture technology 
Cell culture technology has witnessed substantial development in the past few decades and has become an 
essential part of the biopharmaceutical industry. The products derived from cell culture technology are 
used in the health care sector to prevent and treat diseases like viral infections, cancer, heredity 
deficiencies and several chronic diseases. These products have been confirmed to be effective, safe, and 
economical (Ozturk and Hu, 2006). 
Due to the commercial importance of biological products from mammalian cell culture technology there 
is considerable interest in further research and development of these processes. There are a number of 
biological products from these cell lines, such as recombinant proteins, monoclonal antibodies (mAb) and 
nucleic acid based products currently licensed in the market. Among these, monoclonal antibodies have 
dominated the market with large numbers of antibody-based therapeutic products licensed. The most 
prominent ones are Rituxan®, Herceptin®, Remicade®, and Synagis® (Brekke and Sandlie, 2003; 
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Pavlou, 2003). These antibodies have important applications in the management of cancer including 
diagnosis, monitoring, and treatment of the disease.  
1.2 Process improvement in cell culture 
Process or productivity improvement in cell culture technology is of primary concern in 
biopharmaceutical industries. There are various approaches to optimization, such as initial host screening, 
genetic engineering, and process operation. In process operation, it is important to know the 
environmental factors in a bioreactor that can affect cell behavior. This thesis investigates a cell culture 
process for Anti-RhD monoclonal antibody (mAb) production. The mAb productivity in cell culture is 
determined by viable cell density, culture longevity, and specific mAb production rate. Strategies for 
process improvement aim at maximizing these parameters by optimizing culture medium and feeding 
protocol (batch, fed-batch, perfusion and continuous operation, described in further chapters).  
The mammalian cell growth system is highly complex, with a complicated intracellular environment 
consisting of numerous metabolic pathways and reactions occurring simultaneously. Thus understanding 
of biological activity in bioreactors is limited and trial-and-error experimentation or heuristics for cell 
culture process improvement are laborious and expensive.  
Alternatively, the use of mathematical modeling allows for organization of preliminary experimental 
information in a logical and systematic manner, thus facilitating process understanding through the 
identification and quantification of key relationships between process parameters, variables, and product 
output rates. Analysis of these models can help identify parameters that significantly affect antibody 
production. Thus this approach can lead to a possible reduction in the required number of experiments 
with time- and cost-saving implications. In addition, a model can serve in the future to formulate optimal 
operation strategies. 
This thesis focuses on an important factor in cell culture process: apoptosis, or programmed cell death, 
which is prevalent in cell culture, and affects cell growth and thus final product titer. The aim of this work 
is to understand the phenomenon of apoptosis and its interconnection with cell growth for mAb 






Cell culture is an efficient way of producing monoclonal antibodies and various other biological products. 
There has been a rapid increase in the demand for these monoclonal antibody products because of their 
usefulness and the variety of monoclonal antibodies that are required at high doses for application (Butler, 
2005). To meet the current and future demand for monoclonal antibodies, it is necessary to enhance 
productivity by using the various efficient cell lines available and by developing effective manufacturing 
processes. The antibody products are, however, typically formed at very low levels because highly 
specialized culture conditions are required for cell growth and productivity. Host cell lines currently used 
to produce commercial mAb products include murine hybridoma and myeloma cell lines, CHO cell lines, 
and human cell lines. Hybridoma technology was first developed by Kolher and Milstein to produce 
mAb; murine B cells producing a particular antibody were fused to murine lymphoid cells (Kohler and 
Milstein, 1975). With this technology it was possible to produce mAbs for research, analytical use, and 
for limited-dose therapeutic products. However, hybridoma cells are generally difficult to engineer for 
high levels of protein expression and only grow to moderate cell densities in bioreactors (King, 1998), 
thus resulting in low levels of mAb productivity. To overcome these limitations, Chinese Hamster Ovary 
(CHO) cell lines came into practice for mAb production. Today, CHO cell lines have become the 
important workhorses for the production of not only mAbs but also other biological products. Because of 
the extensive application of these hosts, there is a good understanding of their growth behavior and 
metabolism in bioreactors, and the possible host-cell related impurities that might occur in the product. 
Thus an increasing number of products in development are now made using CHO cell lines. 
Considering the fact that the dose requirements of these antibodies are high, it is important to enhance the 
product titer level to more than 1 g/L while culturing the cell lines. There has been substantial work done 
towards increasing product titer by genetic manipulation of cell lines, e.g. by transcription, post-
transcriptional processing, translation, etc. (Bi et al., 2003; Kim et al., 2002; Mangalampalli et al., 2002). 
Along with genetic manipulation there have also been significant advances over the past few years in the 
search for optimal cell culture conditions to further improve mAb production (Andersen and Reilly, 2004; 
Wurm, 2004). Obtaining higher cell density in reactors is considered to be the most important aspect 
toward increasing productivity. This can be achieved through manipulation of the medium composition 
and culture conditions. 
Programmed cell death, or apoptosis, is one of the key issues that must be addressed if the goal is 
obtaining higher cell density for enhanced productivity. Apoptosis restricts cell growth and production in 
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bioreactors and ultimately decreases cell yield. It causes a reduction in cell viability, both directly and 
indirectly, through the release of harmful metabolites and proteases that damage the remaining viable 
population and may inactivate the product. Apoptosis is triggered by a cascade of cysteine proteases 
called caspases, which are activated in response to various insults that may develop in bioreactors during 
batch or fed batch cultures. It has been observed that apoptosis is a common mode of cell death in CHO 
culture, especially in the post-exponential growth phase (Franek and Dolnikova, 1991; Golstein et al., 
1991; Goswami et al., 1999). 
Optimization of cell culture processes for the enhanced productivity of mAb is a highly challenging task 
and it cannot be easily performed by trial and error. Therefore the work in this research describes the 
development of a detailed model to be used towards optimization of cell culture. Such an approach would 
speed up the task of optimization and enhance the understanding of the underlying production process.  
Mammalian cell culture involves complex metabolic networks. Previous studies have used metabolic flux 
analysis to construct mathematical models of mammalian cell culture processes by correlating cell growth 
to metabolic activities triggered by extracellular nutrient availability (Bonarius et al., 1996; Follstad et al., 
1999; Gao et al., 2007). As nutrients are depleted and metabolic activity slows down, growth stops and 
apoptosis is triggered.  Apoptosis accounts for the majority of cell death in bioreactors (Franek and 
Dolnikova, 1991; Golstein et al., 1991; Goswami et al., 1999) and so it significantly impacts cell density 
and viability, and thus product titer. A major cause for apoptosis in batch culture is likely depletion of 
vital nutrients such as glucose (Goswami et al., 1999)  and amino acids such as glutamine and asparagine 
(Sanfeliu and Stephanopoulos, 1999; Simpson et al., 1998b).  Precisely which nutritional deficiencies 
trigger apoptosis is currently unknown. In the models mentioned above, cell death by apoptosis was not 
explicitly addressed.  Instead, the rate of overall cell death (including apoptosis) was correlated to the 
depletion of primary nutrients (glucose, glutamine) or high levels inhibitory products (ammonia, lactate) 
formed during the culture process. However, apoptosis can be triggered well before the depletion of 
glucose, glutamine or even when the levels of inhibitory metabolites like ammonia or lactate are low 
suggesting that in some cases there are additional factors involved (Ljunggren and Haggstrom, 1994). 
Efforts have been devoted in the development of mathematical models of apoptosis (Choi et al., 2007; 
Eissing et al., 2004; Fussenegger et al., 2000; Spencer and Sorger, 2011).  These models address the 
intracellular signaling networks of apoptosis. Although these generic models are comprehensive, and 
incorporate the effect of metabolic stress, their use in specific culture settings is limited, since they were 
not directly correlated with specific extracellular metabolic products, nutrient depletion, or cell density. 
Moreover, these models are specifically based on single cell level, thus their use may be limited since 
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each cell in a cell culture will be at different stages of growth, thus preventing its use in the presence of 
overall cell population in cell culture. The fact that these are single cell models also explains why these 
models have not been properly verified by experiments. 
Operation of the cell culture process in either fed-batch or perfusion modes is another way of enhancing 
cell density and thus productivity (Detremblay et al., 1992; Lee et al., 2005; Nguang et al., 2001; 
Trampler et al., 1994). With these modes of operation, it is possible to reach higher cell density and 
prolonged sustainability of cell viability. However, apoptosis occurs in these modes of operation as well; 
leading to the accumulation of cell-derived materials in the medium due to membrane disintegration and 
cell fragmentation, which also result in higher downstream processing cost of the product of interest. In 
addition, the release of intracellular contents or proteins from the apoptotically lysed cells into the 
medium can affect the product quality. These effects could be overcome by delaying the onset of 
apoptosis in the early phase of culture, resulting in high cell density, and high product titer and quality.  
In previous studies of mAb-producing hybridoma cell lines  it has been observed that the cells continue 
producing mAb even during the stationary phase indicating that the apoptotic cells also produce mAb, 
albeit at a different rate than normal viable cells (Dorka et al., 2009). This fact motivated the need for 
modeling separately the amount of apoptotic and viable cell populations (Linz, 1999). 
To address all the above mentioned issues, a model of apoptosis in Chinese Hamster Ovary cell culture 
was developed and interlinked with a metabolic flux model to arrive at a comprehensive description of 
mammalian cell culture, thus providing a useful tool for process improvement.  Specific objectives and 
novel contributions of this thesis are: 
 Development and calibration of a model at the cellular level to describe the evolution of key 
intracellular components involved in apoptosis  
 
This model is based on differential equations describing mass balances of the corresponding 
reactions. Time-course predictions for the concentrations of intracellular components were 
obtained from the solution of the differential equations. The key parameters of this model were 
estimated via numerical optimization techniques. The model investigates cell density effect in 
cell-cell signaling. After finding that glucose and glutamine are not limiting the cell growth, the 





 Investigation of volume dependency effect in cell culture 
 
Since nutrients such as glucose and glutamine and associated toxic metabolites such as lactate and 
ammonia were found not to be limiting the growth, the effect of initial culture volume was 
investigated. It was found that the growth was actually driven by the inhibitory effect of drop in 
pH possibly due to CO2 accumulation. The inhibitory effect was more pronounced in higher 
volume. The model was modified to take this inhibition into account. 
 
 Coupling of population-based apoptosis model to a dynamic metabolic flux model (developed by 
another PhD candidate in the group, Naderi et al., 2011) incorporating extracellular metabolites 
and prediction of mAb concentration with this combined model 
 
Previously reported models have only described the extracellular metabolites or the intracellular 
species separately but have not linked both together into one model as done in this work. This is a 
novel approach for modeling cell culture process that is expected to provide a more accurate 
description of the process. The predicted concentrations of species obtained from this combined 
model of intracellular caspases relevant to apoptosis and metabolic extracellular fluxes were used 
to describe the mAb production by apoptotic and viable cells present in the culture.  
 
 Investigation of optimization of mAb concentration and the reversibility of cessation in culture 
growth 
 
Cell growth occurs normally during exponential phase and then the growth stops due to cell cycle 
regulations influenced by various environmental factors such as nutritional or toxic stress. After 
investigating the inhibitory effect of pH depression possibly due to CO2 accumulation in CHO 
culture under study, the reversibility of cessation in cell growth via full perfusion of culture was 






1.4 Thesis outline 
The remainder of the thesis is organized as follows 
Chapter 2 presents a literature review of mammalian cell growth, monoclonal antibody production, 
apoptosis, various methodologies available to assess apoptosis and existing efforts towards intracellular 
modeling of apoptosis. Chapter 3 describes the materials and methods applied in this research. Chapter 4 
presents the work performed towards the investigation of cell density effect as means of cell-cell 
signaling in cell culture triggering apoptosis. Chapter 5 presents modeling work on apoptosis progression 
in current CHO cell culture. Chapter 6 describes the investigation of the effect of serum levels on cell 
culture growth with different initial cell density. Chapter 7 presents the investigation of the effect of cell 
culture volume on cell behavior. Chapter 8 describes a comprehensive model by connecting an apoptosis 
model with a metabolic flux model and then to monoclonal antibody production. Chapter 9 presents the 
investigation of reversibility in growth inhibition for improving viable cell density in culture. Finally, 














Chapter 2  
Literature review 
This chapter reviews literature on cell culture, programmed cell death or apoptosis, various methods of 
detection of apoptotic proteins, intracellular modeling of apoptotic pathways and summarizes generic 
mathematical approaches including apoptosis modeling. 
2.1 Mammalian cell culture and products 
Biological products manufactured from mammalian cell culture have significant importance in medical 
and clinical applications. The production of viral vaccines was the first application of mammalian cell 
culture for therapeutic purposes. The cells used were primary cells such as monkey kidney cells and 
chicken embryo cells. These cells are anchorage dependent, requiring a surface to grow. Furthermore, 
these cells strictly require growth factors such as serum for growth. This restriction led to the adoption of 
BHK (Baby hamster kidney) cells, which can be grown in large scale in suspension bioreactors. Although 
this cell line was accepted for veterinary vaccines it was not initially accepted for human applications 
because of safety concerns since the cells contain tumorogenic agents and virus-like particles which were 
unacceptable to regulatory bodies (WHO, FDA). Eventually the use of human diploid cells such WI-38 
and MRC-5 was approved for human applications (Petricciani, 1995). These are normal cells, virus-free 
and contain no carcinogenic components. However, because of their short life span and anchorage-
dependent characteristics, growing these cells is challenging for large-scale production. Consequently, 
continuous cell lines like BHK, myeloma cells (SP2/0, NS0), Chinese hamster ovary (CHO), and human 
embryonic kidney (HEK) cell were gradually adopted for mammalian cell culture applications. These 
continuous cell lines can be grown in suspension in agitated and aerated bioreactors, and thus they are 
suitable for large scale production. 
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Monoclonal antibodies (mAb) have emerged as potential biopharmaceuticals with significant economic 
importance. The first mAb to be approved for clinical applications in humans was a murine antibody 
IgG2, OKT3 (derived from its origin - Ortho Pharmaceutical Corporation, lab of Patrick Kung), also 
referred to as murumonab (Hooks et al., 1991). This was followed by several chimeric mAbs containing 
both murine and human regions. These early antibody products posed a moderate risk of immunogenicity 
to patients from their residual murine components, somewhat limiting their further development. To 
address this issue, new technologies for creating mAbs, predominately or entirely of human origin, were 
developed. Currently, almost all antibody products in development are humanized or fully human.  
2.2 Characterization of cell culture 
Production of biopharmaceuticals from mammalian cell culture is accomplished in various bioreactors for 
large scale production. The characteristics of cells keep changing during culturing in batch or fed batch 
mode. Cell morphology (cell size and cell surface structure) is a clear indicator of the state of a cell. Cells 
usually become larger in size during exponential growth phase and smaller during stationary phase. In the 
late phase of a batch culture, the membrane surface undergoes typical structural changes. This is later 
followed by the disappearance of microvilli and appearance of blebs. The variation in cell morphology 
can be correlated to cell growth and death via the cell cycle. Because of active proliferation with higher 
proportion of cells in the S-phase of the cell cycle, cells increase in size during the exponential phase (Al-
Rubeai et al., 1991; Lloyd et al., 2000). 
2.2.1 Cell cycle 
In cell culture, heterogeneity exists in terms of the stages at which cells are in the cell cycle. The cell 
cycle is the process where a cell duplicates its contents and divides into two to produce genetically 
identical daughter cells. Non-dividing cells are considered to be outside of the cell cycle. 
A cell progresses through the four phases of the cell cycle: G1, S, G2 and M (Figure 2.1). The cell cycle 
begins with the G1 phase (G refers to gap). During this phase a cell feeds on nutrients supplied in the 
medium, synthesizes RNA and proteins. The cell grows in size and readies itself for DNA replication in 
S-phase. During the S-phase, the cell synthesizes DNA. This phase ends when the DNA content of the 
nucleus has doubled and the chromosomes have replicated. The cell then proceeds to the G2-phase where 
it produces new proteins and grows further in size. Finally, it enters the M-phase during which nuclear 




Cell cycle advancement is regulated by CDKs (cycline-dependent kinases which add phosphate to 
proteins) that get activated by binding of regulatory subunits called cycline (Sherr and Roberts, 1999; 
Sugimoto et al., 2002). Depending upon the environmental or developmental signals, cells in the G1 
phase may leave the cell cycle during which the cells become non-dividing and remain in a quiescent 
metabolism where protein synthesis and cellular functions continues but where there is no cellular size 









Figure 2.1: Cell cycle (R1, R2: restriction points) 
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Most of the cells in human body tissues and organs, such as postmitotic neurons and skeletal muscle cells 
are in non-dividing state. A cell may remain in this state for an indefinite time until signaled to continue 
through the whole cell cycle. For differentiated neurons this G0 state is permanent (Chanas-Sacre et al., 
2000; Yoshikawa, 2000). Growth arrest can be caused by withdrawal of serum growth factors and 
nutrients. In many cases accumulation of p27 is believed to be the major factor for reversible G0/G1 
arrest caused by growth factor deprivation or high cell density in culture (Polyak et al., 1994). But 
withdrawal of growth factors is not the only way to arrest the cell cycle in G0 state. Induction of CDK 
inhibitors such as p21, p53, p16, p57 can cause cell cycle arrest in the presence of serum. This form of 
growth arrest is usually considered to occur during the late G1 phase. The durations of S, G2, and M 
phases are relatively constant, while the duration of the G1 phase, particularly the early G1 phase, is more 
variable (Baserga, 1985). 
Cellular senescence is a state that occurs in response to DNA damage or degradation that would make the 
cell nonviable. Nutrient depletion can lead to DNA damage (Weinberger et al., 2007). A protein p53 
blocks the cell cycle by inhibiting CDK activity in case of DNA damage and its levels are increased in 
damaged cells. Activation of p53 allows time and opportunity for DNA repair before DNA replication 
and mitosis (Hartwell and Kastan, 1994).  If the damage is severe and irreparable, p53 induces apoptotic 
cell death as a mean for eliminating faulty cells.  
The cell cycle comprises checkpoints that sense possible defects in DNA synthesis and chromosome 
distribution for appropriate cell cycle progression.  During the developmental G1 stage there may be some 
errors in functions performed during the cell cycle. At this point the cell may decide whether to proceed 
to the next phase (S-phase) or not. This is the first checkpoint or restriction point (R1) which is present 
just before the S-phase (Pardee, 1974). After passing this point, cells are committed to the S-phase. 
Cellular senescence can be thought of occurring at this check point that can lead to apoptosis. 
Another check point is present in the G2-phase referred to as R2. A check is made on the successful 
replication of DNA that takes place during S phase. If replication stops at any point on the DNA, progress 
of the cell cycle is halted until the fault is repaired. If not, a cell destroys itself through apoptosis. 
A more thorough review on cell cycle progression in mammalian cells can be found in (Fussenegger and 
Bailey, 1998). A study on the population distribution of hybridoma cells during perfusion was carried out 
by flow cyometric analysis (Park and Ryu, 1994). It was shown that the proportion of cells in the S-phase 
decreases during the decline period of a perfusion culture, and the proportion of cells in the G0/G1 phase 
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increases with decreasing growth rate. Also it was shown that the proportion of cells in the G2/M-phase 
was relatively constant throughout the perfusion culture. 
2.2.2 Cell culture selection for biotherapeutics production 
Chinese hamster ovary (CHO), mouse myeloma (NS0), baby hamster kidney (BHK), murine C12, human 
embryo kidney (HEK-293) or human-retina-derived (PER-C6) cell lines are used for the cell culture 
production of various recombinant biotherapeutics. However, CHO cell lines are the most used host cells 
for biotherapeutics production as these cell lines have excellent capability of suspension growth. The 
other cell lines, except NS0 and HEK-293, are characterized for their anchorage dependent nature and 
need special efforts to make them adapt to suspension growth environment. CHO cell lines are well-
characterized in terms of efficient transfection, amplification and screening for high producer clones. 
These cell lines are also considered as reasonably safe by regulatory bodies such as FDA. Overall, CHO 
cell lines are the foremost source organisms for the production of various biological products because of 
their high capacity for suspension growth, good quality and product safety in therapeutic applications. 
Recombinant cell lines transfected with a target gene are used for utilization in cell culture. dhfr 
(dihydrofolate reducatase) and GS (glutamine synthetase) are the most widely used selectable marker 
systems for cell lines.  
CHO cell lines are customarily used with dhfr systems.  In dhfr systems, a target gene is transfected along 
with dhfr marker gene into a cell line deficient in dhfr activity. The dhfr
-
 cells are unable to synthesize an 
essential metabolic enzyme, dihydrofolate reductase, involved in biosynthesis of nucleotide components. 
After transfection, the transfected cells that express the dhfr gene are capable of growing in media in the 
absence of glycine, hypoxanthine and thymidine. MTX (Methotrexate), which is an inhibitor of dhfr 
enzyme activity, can be used for amplication of the dhfr gene (Gandor et al., 1995; Pallavicini et al., 
1990). By subjecting the cells to an increasing concentration of MTX for several rounds, amplification of 
the dhfr gene and target gene can be obtained. Thus it is possible to produce a clone with higher specific 
productivity following an increased gene copy number.  
In the GS system, cell lines, having insufficient capability of expressing the GS gene, are co-transfected 
with the GS gene. The GS enzyme enables the intracellular synthesis of glutamine, thus the cells 
surviving in a glutamine deficient medium are selected for the production of biological products. CHO 
cells have the capability to express the GS enzyme to grow in glutamine-free media. High-level 
expression cell lines can be obtained by subjecting these CHO cell lines to low level of MSX (methionine 
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sulphoximine), a GS inhibitor (Cockett et al., 1990). Myeloma cells (NS0) do not have sufficient 
capability to express GS since they need glutamine in the media to survive. These cells, after GS 
transfection and growth in the glutamine-free media, can be selected for high expression clones by using 
low levels of MSX than that required for CHO cell lines. The advantage of this GS system is that less 
ammonia is produced thus reducing the toxicity to the cells (Zhang et al., 2006). 
2.3 Bioreactor operation modes 
The operation of mammalian cell cultivation is an essential aspect of productivity and product quality. 
The operation modes for cell cultivation can be divided into batch, fed batch, continuous culture with 
partial cell retention (chemostat or cytostat) and continuous culture with cell retention (perfusion). Figure 
2.2 shows the schematics of different modes of operation. 
2.3.1 Batch culture 
In this mode of cultivation, the cells and medium are charged into a bioreactor and no further addition or 
withdrawal of cells or medium during the process is done (Figure 2A). At the end of the process the entire 
reactor content is harvested at once. The cells grow in suspension  exponentially consume nutrients 
(glucose, amino acids etc.) and produce metabolic waste products (e.g. lactate, ammonia and CO2) until a 
maximum cell density for a given medium is reached due to nutrient limitation or waste product 
inhibition. 
It is the simplest operation, relatively short in duration and it is the preferable choice of cultivation in 
much industrial cultivation due to low risk of contamination, while easing implementation, scale up and 
validation. However, batch processes suffer from problems of nutrient depletion, low cell densities, low 
productivity and accumulation of toxic metabolites that may hamper product quality. Also, the down-time 
between batches may be too long resulting in overall less productivity.  
Most of the cell lines have been used for cultivation in batch mode. In standard cell culture media cell 
densities in the range 1-4 x 10
6
 cells/mL have reached (Lee et al., 2003; Merten, 1987; Ozturk and 
Palsson, 1990a). In other studies, significantly higher cell densities of  >10
7
 cells/mL have been reported 
to be achieved for hybridoma cells (Jo et al., 1993). 
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2.3.2 Fed-batch culture 
To overcome early nutrient depletion, fed-batch mode is usually implemented. Fed-batch culture is 
characterized by a continuous or intermittent feed of nutrient, thus helping achieve higher cell density and 
product formation compared to batch operation (Figure 2.2B). Since no cell suspension or supernatant is 
taken out from the bioreactor during the process, the volume increases till the entire material is harvested 
at once. With this mode of operation the culture duration is prolonged from a few days to weeks. 
Generally high productivity is obtained as compared to batch operation due to the prolonged 
accumulation of product. Optimization of feeding strategies involving optimal feeding solution and feed 
rate controls are an essential part of this operation to obtain higher product titer by minimizing nutrient 
depletion and minimizing the formation of toxic metabolites e.g. lactate and ammonia. In CHO cell 
culture the cell density could be increased by fed-batch operation to 5 x 10
6
 cell/mL (Xie et al., 1997). 
Fed batch has also been applied in large scale in 25000L working volume for large scale production of 
antibody (Birch and Racher, 2006). In hybridoma cell culture the cell density has been reported to be in 
the range of 3-17 x 10
6
 cell/mL (Xie and Wang, 1996) and productivity to be 10-fold compared to simple 
batch culture (Robinson et al., 1994; Xie and Wang, 1994). In insect cell fed-batch culture cell density in 
the range of 5 x 10
6
 cell/mL has been reported (Elias et al., 2000).  
A review of fed-batch culture in monoclonal antibody and other recombinant protein production can be 
found in (Wlaschin and Hu, 2006; Bibila and Robinson, 1995; Xie and Wang, 1997).  
2.3.3 Continuous culture 
In continuous culture or chemostat (chemical environment is static), fresh nutrient medium is added 
continuously to the bioreactor with simultaneous partial withdrawal of cell suspension at the same rate, 
keeping the culture volume in the reactor at constant (Figure 2.2C). The reactor content is well mixed 
ensuring the concentration of cells, nutrients, and metabolites in the vessel is the same as those in the 
effluent stream.  Because of the continuous addition and removal, the possibility of nutrient depletion and 
accumulation of toxic metabolite is reduced. While transient changes of most of the parameters are 
observed in batch culture, continuous operation enables the study of the effect of different culture 
variables under steady state environmental conditions. A number of studies have been reported in 
characterization of growth and metabolism over a wide range of dilution rates for CHO cells (Heidemann 
et al., 1998; Nyberg et al., 1999), hybridoma cells (Frame and Hu, 1991; Ray et al., 1989; Vriezen and 
van Dijken, 1998) and BHK cells (Carrondo et al., 1999; Hu et al., 2000). 
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This mode of operation requires a higher level of technical skill to operate as compared to batch or fed-
batch cultures. Continuous prolonged operation is subject to genetic changes in cells that can lead to low 
productivity. 
2.3.4 Perfusion culture 
In this mode of operation fresh medium is fed in the bioreactor continuously or semi-continuously and 
cell-free supernatant constantly removed at the same rate while retaining or recycling cells back to the 
bioreactor (Figure 2.2D). Thus, in this mode of operation, the accumulation of high levels of toxic or 
inhibitory metabolites that might have negative impact on the productivity is avoided. This mode of 
operation offers high cells densities and productivities compared to batch, chemostat and even compared 
to fed-batch.  Spin filters, hollow fibers and decanters are used for the retention of cells. The perfusion 
rate depends on the type and culture behavior of the cell line, the concentration of nutrients in the feed 
and the level of toxicity. This mode of operation has been used for the production of monoclonal 
antibodies (Banik and Heath, 1995; Tang et al., 2007; Yang et al., 2000) and recombinant proteins (Al-






Figure 2.2: Culture operation modes (A) Batch culture operation (B) Fed-Batch culture operation (C) 
Continuous culture operation (D) Perfusion culture operation 
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An example of a 500 L industrial perfusion system for monoclonal antibody production by hyridoma  is 
described by (Deo et al., 1996) where the operation continued for 15 to 35 days to achieve commercial 
production of antibodies with a cell density of >10 x 10
6
 cell/mL. Their results have shown that the 
volumetric productivity of the perfusion process was approximately 10 times that of batch or fed-batch 
cultures. Large scale cultivations are running at Bayer (Boedecker, 1994), Chiron (Gray et al., 1996), and 
Novartis (Bachinger et al., 2000) and others. Bayer launched coagulation factor VIII, the first 
biopharmaceutical produced by recombinant BHK cells using a continuous perfusion culture obtaining a 
30-fold increase in cell density that results in a 30-fold higher yield of factor VIII compared to the batch 
culture, over a period of 185-day production process. This leads to significantly reduced requirements for 
plant capacity, i.e. a 100-500 L perfusion reactor vs. a 5,000-15,000 L batch reactor (Boedecker, 1994). 
The overall advantage of perfusion cultures is that they require smaller scale compared to batch cultures. 
However, a disadvantage of the perfusion system is the additional time and complexity involved in 
developing the process and added risk for contamination. Operating a perfusion bioreactor is expensive 
because of the continuous addition and removal of medium, operating equipment like pumps and 
membranes to supply medium to the bioreactor and also the extra cost to treat the waste medium (Shuller, 
2002). 
2.4 Cell death in bioreactors 
Cell death occurs as a result of two distinct processes: necrosis and apoptosis.  
2.4.1 Necrosis 
Necrosis is an accidental, passive, uncontrolled death and is referred as “cell murder” (Darzynkiewicz et 
al., 1997). This is caused when the cells are exposed to sudden and harsh cellular damage occurring upon 
severe changes in culture conditions such as shear stress on cell membrane due to collision with the 
bioreactor wall or stirrer, exposure to high levels of toxic metabolites (Singh et al., 1994).  
2.4.2 Apoptosis 
Apoptosis is an active, intrinsically controlled cell death and referred as “cell suicide” (Majno and Joris, 
1995). It occurs as a regulated response to specific shifts in the culture environment. This non-optimal 
change, which in some cases is inevitable, is associated to many causes as follows, 
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2.4.2.1 Nutrient depletion 
Depletion of some essential nutrients such as glutamine (Sanfeliu and Stephanopoulos, 1999; Simpson et 
al., 1998a), glucose (Goswami et al., 1999), growth factors and oxygen (hypoxia) (Ishioka et al., 2007; 
Malhotra et al., 2001) has been found to trigger apoptosis in cell culture. 
2.4.2.2 Serum withdrawal 
Serum is an essential component that fulfills an important role in cell growth and cell survival. Serum 
contains many important growth factors, hormones, vitamins and other nutrients which are essential for 
the normal growth of the cell. Depletion of specific components in serum triggers nutrient stress leading 
to apoptosis in hybridoma and CHO cells (Bailey et al., 1999; Even et al., 2006), and plasmacytomas 
(Singh et al., 1994). 
2.4.2.3 Dissolved CO2 and osmolality 
CO2 in cell culture process is generated by biotic sources i.e. cellular respiration, and abiotic sources such 
bicarbonate (NaHCO3) or carbonate (Na2CO3) added as a buffer to control the pH of the cell culture 
medium (Goudar et al., 2006).  At high viable cell concentrations in large scale cell culture processes, 
dissolved CO2 can accumulate due to low removal rates at reduced bioreactor surface-to-volume ratio 
(Pattison et al., 2000). As CO2 accumulates in the bioreactor, it dissolves in the cell culture medium as 




         
      
  
The decreased in pH (increase in H
+
 ions) has detrimental effects on cellular metabolism by affecting 
enzyme activity.  
The solubility of a gas in a solvent is directly proportional to the partial pressure of that gas above the 
solvent and is given by Henry‟s Law as  
         [   ]
  
where [   ]
  is the CO2 concentration in equilibrium with the gas phase,      is the partial pressure of 
CO2 and      is Henry‟s Law constant (Pa/M).  The physiological concentration of CO2 that is required 
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for the normal growth of cells is 0.04-0.07 atm, i.e., an aqueous phase concentration in equilibrium with a 
gas phase with a CO2 partial pressure of .041-0.071 atm (Schmelzer and Miller, 2002). 
The HCO3‾ and the base (e.g., NaOH) added to control the pH of cell culture medium contribute to 
increased medium osmolality. Increased osmolality alters membrane exchange activity to maintain cell 




) which can further 
adversely affect intracellular enzyme activity. Hence, increase in CO2 accumulation results in increased 
medium osmolality. The elevated levels of osmolality itself unfavorably affect cell growth and 
metabolism. It is therefore important to decouple the effect of dissolved CO2 and osmolality. 
Most of the studies related to the effect of CO2 on cell behavior are actually combined effects of CO2 and 
osmolality. In studies of CHO cell culture, a very little or no change in growth rates was observed at 
higher CO2 concentrations of 0.18 and 0.26 atm (at an osmolality of 310 mOsm/kg) compared to the 
control at a CO2 concentration of 0.05 atm (at an osmolality of 310 mOsm/kg). However, there was a 
decline in the growth rate by 30% when CO2  concentration increased from 0.05 to 0.33 atm (at an 
osmolality of 310 mOsm/kg) (Kimura and Miller, 1996). In studies of CHO cell culture in a 10 L 
bioreactor, a decrease in the cell viability from 79% to 58% was observed with increasing CO2 
concentration from 0.05 to 0.6 atm (osmolality of 310 to 340 mOsm/kg) (Gray et al., 1996).  
On the contrary, investigations conducted with increased osmolality of 357 and 376 mOsm/kg  at 0.05 
atm CO2  in CHO cell culture increased the specific death rate by 30% and 60% compared to the control at 
an osmolality of 310 mOsm/kg (Dezengotita et al., 1998). Combination of elevated CO2 concentration 
and osmolality had a detrimental effect on cell growth (Dezengotita et al., 1998; Kimura and Miller, 
1996; Zhu et al., 2005). A decrease in growth rate by 45% was observed at 0.33 atm and 376 mOsm/kg 
compared to the control at 0.05 atm and 310 mOsm/kg in  cell culture of CHO cells in T-150 flasks 
(Kimura and Miller, 1996). It has been shown that apoptosis was the main mechanism of cell death of 
hybridoma cells at elevated levels of partial pressure of CO2 and osmolality (DeZengotita et al., 2002).  
Aunins and Henzler, (1993) had observed an early cell death in NS0 myeloma cell cultures with a final 
CO2 of 0.16 atm. However, the specific production rates of IgG by cells remained unaffected. 
2.4.2.4 pH 
pH is another parameter that has a large effect on growth in cell culture. During the culture, changes in 
pH occur that can affect cell growth. As discussed above, CO2 accumulation in culture medium is a major 
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cause of decrease in pH during the culture which affects the intracellular pH. Deviation of pH away from 
its optimal range can have a significant effect on cell growth and productivity via apoptosis.  While most 
of cell culture media offer substantial buffering of pH, cellular metabolism invariably decreases pH due to 
the secretion of lactic acid and CO2 accumulation. 
The effect of pH shift on cell growth and productivity in batch culture of GS-NS0 mouse myeloma cell 
line was investigated by Osman et al., (2001) and Osman et al., (2002) over the range of pH 6.5 to 9. The 
pH shift was obtained by manipulating dissolved CO2 concentration by CO2 sparging or CO2 stripping 
(nitrogen/air stripping). It was shown that pH shift above 0.2 units can cause a transient increase in 
apoptotic cell death. The pH shift between the values 7.0 and 8.0 continued the cell growth. On the other 
hand cultures that shifted below 7.0 and above 8.0 did not recover, resulting in cell death. They found that 
the maximum specific growth rate and maximum viable cell number occurred at pH 7.3 while product 
formation was found optimum at pH 7.0. In the studies conducted by Gottlieb, (1996), intracellular pH 
shift has been described as a trigger of apoptosis in various cell culture systems. Similarly, in the studies 
carried out by Al-Rubeai and Ishaque, (1998) in hybridoma cell culture, it was found that the intracellular 
acidification is a clear indication of apoptosis since it induces cellular destruction and cell death.  
2.4.2.5 Toxic metabolites 
Accumulation of toxic metabolites such as lactate and ammonia during the culture is also responsible for 
triggering apoptosis. Lactate build-up leads to the acidification of the culture environment. In addition, 
lactate itself could also be toxic to mammalian cells even under optimal pH values (Hassell et al., 1991; 
Lao and Toth, 1997; Ozturk et al., 1992; Singh et al., 1994). 
2.4.2.6 Cell density 
Higher cell density has also been found to trigger apoptosis in cell culture via cell-cell communication 
(Ishizaki et al., 1994; Mathieu et al., 1995; Saeki et al., 1997). It is hypothesized that the effect of density 
is due to the lack or reduction of survival signals provoked by direct cell-cell contact or soluble growth 
factors (autocrine factors) produced by the cells. 
2.4.2.7 Oxygen  
Other insults like excess oxygen (hyperoxia) have also been found to promote apoptosis (Emery et al., 
1995; Laken and Leonard, 2001). Deprivation of oxygen has also been shown to be a trigger for apoptosis 
(Mercille and Massie, 1994b). 
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Another form of cell death has also been identified and is being widely studied, this is called autophagy 
which is a normal cell degradation process without the involvement of caspases (Gozuacik and Kimchi, 
2004; Broker et al., 2005). It can be triggered by nutrient depletion, hyperosmotic stress or viral and 
microbial infection (Mortimore and Poso, 1988; Hwang and Lee, 2008; Han et al., 2010). 
2.5 Morphological characteristics of cell death 
Cells undergo unique morphological changes during death. In apoptosis, the morphological changes start 
occurring in the cell nucleus. Simultaneously, the cytoplasm looses water and the cellular cytoskeleton 
breaks down leading to cell deformation and shrinkage. Then, the chromatin condenses followed by 
extensive blebbing of the plasma membrane and separation of fragments into apoptotic bodies. This event 
is referred to as “budding”. 
Apoptotic bodies consist of cytoplasm with tightly packed organelles with or without a nuclear fragment. 
The organelle integrity is still maintained and it is enclosed within an intact plasma membrane. These 
apoptotic bodies can be phagocytosed in vivo although in vitro they might break apart or accumulate 
during the cell culture process. 
Necrosis on the other hand results in swelling of the cell, rupturing of the plasma membrane, release of 
cytoplasmic contents to the extracellular environment and cell lysis (Leist and Jaattela, 2001). During 
necrotic death, neither specific signaling nor particular degradation of DNA has been observed (Mercille 
and Massie, 1994a). Figure 2.3 shows the morphological changes during the progression of apoptosis and 
necrosis respectively. 
Caspases are the prime mediators of apoptosis. At least 14 different caspases, to date, have been identified 
in mammalian cells (Droin et al., 2008; Cohen, 1997). Members of the caspase family can be divided into 
three groups. (1) Initiator caspases (e.g. caspase-2, 8, 9 and 10), executioner caspases (e.g. caspase-3, 6 
and 7) and participants in cytokine activation (e.g. caspase-1, 4, 5, 11, 12, 13 and 14). Caspase-8, 9 and 3 
have been the most widely studied caspases. Caspases share similarities in their sequences, structure and 
substrate specificity. Two cleavage events are involved during the activation of caspases. The first event 
involves cleavage of the protein chain into large and small caspase subunits, and a second cleavage 
removes the N-terminal pro-domain. The active caspase is a tetramer of 2 large and 2 small subunits, with 












2.6 Apoptotic pathways 
There are two widely reported main pathways so far through which the apoptotic cascade proceeds. These 
are the receptor-mediated pathway and the mitochondrial-mediated pathway. These are explained as 
follows 
2.6.1 Receptor-mediated pathway 
This pathway of apoptosis is initiated by the binding of some extracellular protein ligands to their cognate 
transmembrane death receptor proteins (Aggarwal, 2003; Ashkenazi and Dixit, 1998; Schulze-Osthoff et 
al., 1998). This is also referred to as the extrinsic pathway (Figure 2.4). The receptors involved in this 
pathway are the members of the tumor necrosis factor (TNF) type I superfamily (Arden and Betenbaugh, 
2004; Huerta et al., 2007). 
The ligands and their corresponding cognate receptors identified so far are: FASL/CD95L/Apo1L-
Fas/CD95/Apo1, Apo2L-DR4, Apo3L-DR3, TNF-α/TNFR1. The death receptors contain a cytoplasmic 
tail called death domain (DD) which upon  ligation recruits an adaptor protein such as FAS associated 
death domain (FADD) or TNF-related associated death domain (TRADD) (Golstein, 1997; Schulze-
Osthoff et al., 1998). This adaptor protein also contains its own death domain (DD) by which it gets 
recruited to DDs of a death receptor thus forming the so-called death-inducing-signaling complex (DISC).  
The adaptor protein also contains a death effector domain (DED) which through DED-DED interaction 
recruits two pro-caspases, which activate each other by proteolytic cleavage. The two caspases that are 
bound to these adaptor molecules are mainly caspase-8 or caspase-10. These activated caspases stimulate 
a downstream cascade where other caspases, including executioners caspase-3 or caspase-7 are activated 
resulting in apoptosis. 
The receptor mediated pathway also communicates with the mitochondrial pathway through the small 
pro-apoptotic Bcl-2 homolog, Bid, which is activated by caspase-8 cleavage to generate truncated Bid 
(tBid). Activated tBid translocates to the mitochondrial membrane, where it creates pores and stimulates 
the activation of the mitochondrial apoptosis cascade through an interaction with the pro-apoptotic Bax or 
Bak proteins (Zha et al., 2000). 
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2.6.2  Mitochondrial pathway 
This pathway is also referred as the intrinsic pathway because it is triggered by signals from the 
intracellular environment. This however does not mean that the initial stress signals originate in the 
intracellular area. This pathway is initiated by the release of cytochrome-c from the mitochondria in 
response to various stresses like nutritional stress, amino acid limitation, hypoxia, exposure to toxic 
components or UV radiation (Goswami et al., 1999; Kluck et al., 1997; Sanfeliu and Stephanopoulos, 
1999; Simpson et al., 1998a). 
It is proposed that the release of cytochrome-c can be either permeability transition (PT) pore-dependent 
or independent. In the permeability transition (PT) pore-dependent mechanism, the pore is opened in 
response to a stress signal. The pore is formed at sites where the inner and outer membranes of the 
mitochondria meet. The pore is composed of adenine nucleotide translocase (ANT), the mitochondrial 
inner membrane protein transporter (Tim), the protein transporter at the outer membrane (Tom), the outer 
membrane voltage-dependent anion channel (VDAC) and cyclophilin-D (Crompton, 1999). 
The opening of a pore can allow molecules smaller than 1.5 kDa to permeate. The entering molecules 
cause an increase of the osmolar load of the mitochondria which brings more water in.  This causes the 
mitochondria to swell and its outer membrane to rupture resulting in release of cytochrome-c into the 
cytoplasm (Yang and Butler, 2000). PT pore independent mitochondrial membrane permeabilisation is 
regulated by the Bcl-2 (B-cell lymphoma 2) family. The members of the Bcl-2 family share at least one 
common structural features of the four conserved regions termed as Bcl-2 homology (BH) domains 
(named BH1, BH2, BH3 and BH4) (Chittenden et al., 1995). The Bcl-2 family can be subdivided into 
anti-apoptotic members such as Bcl-2 and Bcl-xl and pro-apoptotic species. 
The anti-apoptotic Bcl-2 proteins (Bcl-2 and Bcl-xl) conserve all four BH domains. Pro-apoptotic 
members are grouped into two categories based on the expression of BH domains. Multi-domain proteins 
comprise BH domains 1-3 include Bax, Bak, and Bok. The other sub-group, the BH3-only proteins, 
consists of Bad, Bik, Bid, tBid, Puma, Bim, Bmf and Noxa. The BH3-only proteins activate multi-domain 
pro-apoptotic species and disrupt the function of anti-apoptotic Bcl-2 family members (Letai et al., 2002). 
It is thought that multi-domain Bcl-2 family members form channels in the outer mitochondrial 









After being released into the cytoplasm, cytochrome-c binds to adenosine triphosphate (ATP)  and to an 
adaptor protein called apoptosis activating factor-1 (Apaf-1) forming a complex to which procaspase-9 is 
recruited. This entire complex is referred to as an apoptosome complex. This complex in turn facilitates 
the cleavage and activation of pro-caspase-9 which in turn activates caspase-3. SMAC/DIABLO proteins 
and apoptosis inducing factor (AIF) are also released into the cytosol from within the mitochondria. 
SMAC/DIABLO is reported to promote apoptosis by inhibiting IAP (inhibitors of apoptosis proteins) 
activity (Schimmer, 2004). AIF contributes to DNA fragmentation and subsequent chromosomal 
condensation, which are prime features of apoptosis (Susin et al., 1999). 
25 
 
The Bcl-2 family members are key players in the regulation of the intracellular caspase cascade. The 
antiapoptotic proteins resist the activation of caspase-9. They inhibit the release of cytochrome-c from the 
mitochondria and compete with procaspase-9 for Apaf-1 binding sites. Proapoptotic proteins such Bax or 
Bid bind to antiapoptotic Bcl-2 family members, thus neutralizing their inhibitive abilities. The ratio of 
anti-apoptotic versus proapoptotic Bcl-2 family members, for example Bcl-xl to Bax, is tightly controlled 
by p53 (a gene involved in cell cycle regulation). In response to various stimuli, p53 can cause cell arrest 
or apoptosis. Depending on the type of stress and its severity, p53 may cause cell arrest (Zhang et al., 
2005). However, when stress signals are continual and the cell fails to repair damage through cell cycle 
arrest, p53 activation triggers apoptosis through mitochondrial stress and degradation following the 
upregulation of BH3-only pro-apoptotic proteins including; Bax, Noxo, Puma and others (Oda et al., 
2000).  
A third apoptotic pathway has been reported, but not very widely studied. This pathway originates in the 
endoplasmic reticulum (ER) which is a specialized site of protein translation, protein folding, 
modification and transport of secretary/membrane proteins. It is also a specialized site of calcium storage. 
This pathway can be mediated by mitochondria (because of the proximity of mitochondria) or without 
mitochondria. In mitochondrial-independent ER pathway, proteins localized to the ER sense the stress 
signal and activate caspase-12 which subsequently activates caspase-9 (independently of Apaf) which can 
then activate caspase-3 (Rao et al., 2002). The mitochondrial-dependent pathway is initiated by 
fluctuations in Ca
2+
 ions in the ER. This leads to the activation of BH3 only proteins which, upon 
activation, translocate to the mitochondrial membrane leading to apoptosis (Zong et al., 2003). This ER 




2.7 Analytical methods 
There are various common analytical methods that can be used for the detection of apoptosis or proteins 
involved in apoptosis. The applicability of each method depends on its specificity and sensitivity. The 
following sections describe the various analytical methods useful for the identification of apoptosis, 
associated proteins and necrosis. 
2.7.1 Fluorescence microscopy 
Fluorescence microscopy with dual staining of acridine orange and ethidium bromide can be applied to 
differentiate between physiological states of cells (Giuliano et al., 1998). The dye acridine orange can 
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penetrate viable and nonviable cells; it fluoresces green when bound to double stranded nucleic acid, i.e. 
DNA, and fluoresces red if it intercalates into single stranded nucleic acid, i.e. RNA. Ethidium bromide 
can diffuse only into nonviable cells and fluoresces red when intercalated into DNA. Images of the 
stained cells can be processed by the Image J software package (Burger and Burge, 2008). The cells thus 
can be categorized into three groups: (1) Normal viable cells, having organized structure with bright 
nuclei and translucent green cytosol; (2) Apoptotic cells, either in (i) early apoptosis, -- bearing a 
condensed or shrunken nucleus with perinuclear chromatin appearing as green patches, or (ii) late 
apoptosis -- with blebbing on the cell surface, and orange to red condensed or fragmented nuclei;  (3) 
Necrotic cells, having organized structure but with uniformly orange-to-red nuclei. The identification of 
cells with this methodology applied in this work is shown in Section 4 in Figure 4.4 for a set of 
experiments. 
2.7.2 Flow cytometry 
Flow cytometry, also referred as FACS (fluorescence-activated cell sorter), is a very useful technique that 
is able to make multiple simultaneous measurements at the single cell level. This technique relies upon 
the measurement of scattered light fluorescence from suitably stained constituents in individual cells in 
the population. In this method, fluorescently stained cells are passed individually through a focus of high 
intensity light source. As each cell passes through the focus, a flash of scattered and/or fluorescent light is 
emitted. This is collected by appropriately positioned lenses. The optical filters direct the emitted light 
signals to appropriate detectors. The detectors then convert the light flash into an electronic signal which 
can then be processed by a computer. The data collected on each cell or event is stored in a so-called flow 
cytometry standard (FCS) format. The data stored in FCS format are “LIST MODE” data, whereby all 
measurements on each cell are stored separately in a list. Flow cytometry, given a defined threshold 
intensity, provides quantification of the percentage of cells which are positive or negative for the target 
protein to be detected within a population of a given amount of sample or alternatively it provides a 
relative quantification of target proteins.  
As mentioned earlier, the various morphological changes that occur during apoptosis take place in an 
orderly sequence. These can be used to distinguish vital and dying cells, and to analyze the extent and 
type of cell death. Figure 2.5 shows the morphological changes which are captured by flow cytometry 
(Vermes et al., 2000). Apoptosis begins with cell shrinkage expressed by changes in cell light-scatter 
signals. Initially the integrity of cell membrane is intact. The forward light scatter (FSC) is an indicator of 
cell size, while side angle light-scatter (SSC) reflects the conformation or granularity of inner cellular 
structures. As a results of these cellular changes, FSC decreases during the initial stages of apoptosis 
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while SSC increases or remains constant. After that, decrease in both FSC and SSC is observed. During 
necrosis cell swelling occurs due to the loss of membrane integrity. Thus a quick increase in FSC and 
decrease in SSC are observed. 
Flow cytometry is also useful for assessing the cell heterogeneity based on the cell cycle. During the 
batch culture, the fraction of cells in the G1, S and G2/M phases changes significantly. In the esponential 
growth phase, most of the cells are in the S and G2 phases, whereas during the decline phases, the 
majority of the cells are in the G1-phase. By staining the cells with fluorophores such as propidium iodide 
(PI) and acridine orange (AO), this method can be used to analyse the progress of cell cycle in the culture 






Figure 2.5: Analysis of apoptosis with flow cytometry by light scattering of cells (Modified from Vermes 
et al., 2000) 
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Flow cytometry is also used to characterize apoptosis based on morphological features by using the 
annexin-V binding method.  This assay detects the loss of plasma membrane integrity, one of the typical 
features of cells undergoing apoptosis. In cells undergoing apoptosis, the membrane phospholipid 
phosphatidyl serine (PS) is exposed to the external cellular environment, because it is translocated from 
the inner to the outer leaflet of the plasma membrane. Annexin-V is a Ca
2+ 
dependent binding protein that 
binds to PS with a strong affinity. Annexin can be conjugated to fluorochromes such as FITC (fluorescein 
isothiocyanate), APC (allophycocyanin), and PE (phycoerythrin). Another dye, PI (propidium iodide), can 
also be used to label cells which have lost membrane integrity. Using PI in combination with annexin-V, 
can provide information to distinguish  cells  that are at early stages of apoptosis (annexin-V positive, PI 
negative) from cells that are at a late stage of apoptosis (annexin-V positive, PI positive) (Bakalczuk et 
al., 2003; Moore et al., 1998; Overbeeke et al., 1998). 
Flow cytometry is used extensively for the detection of caspases inside the cells or any others proteins 
involved in the apoptotic pathway. The FLICA (Fluorochrome inhibitor of caspases) methodology is a 
very popular method for the detection of caspases in cells by flow cytometry (Arden et al., 2006). The 
FLICA methodology uses a fluorescent labeled inhibitor consisting of an amino acid sequence that targets 
a specific caspase. When this FLICA is added to a population of cells, it enters each cell and covalently 
binds to a reactive cysteine residue of that particular caspase, thereby inhibiting further enzymatic 
activity. The FLICA reagent is covalently coupled to the enzyme and thus is retained in the cell, while 
any unbound FLICA reagent diffuses out of the cell and is washed away. The fluorescent signal is a direct 
measure of the number of active caspase enzymes that were present in the cell when the reagent was 
added. This technique is referred to as intracellular staining. Flow cytometry detection of caspases can 
also be carried out by using cell permeable fluorogenic caspase substrates (Benford et al., 2001; Liu et al., 
2002). Flow cytometry is also used with an antibody based approach. In this case the technique is referred 
to as surface staining since it is usually used for the detection of proteins within the membrane surface. 
FASL, which is a membrane protein, has been detected by flow cytometry by an antibody based method 
(Lorz et al., 2000; Schulte et al., 2007). 
2.7.3 Colorimetry and fluorometry 
These methods can be also used for assessing the progress of apoptosis by measuring caspase activities. 
Many designated substrates and inhibitors have been developed commercially for the investigation of 
caspases in cell culture undergoing apoptosis. Substrate based methods involve the application of a 
synthetic tetrapeptide (recognition sequence) conjugated to a colorimetric molecule, p-nitroanilide (pNA) 
or a fluorescent molecule, 7-amino-4-trifluoromethylcoumarin (AFC). YVAD, VDVAD, VEID, IETD, 
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and LEHD are commercially designated peptide substrates for caspase-1, 2, 6, 8 and 9 respectively that 
can be coupled to either pNA or AFC to make the complete substrate molecule. DEVD is the peptide 
substrate for both caspase-3 and caspase-7. There are also caspase specific inhibitors which are developed 
based on specific caspase substrates. This inhibitor design includes tetrapeptide recognition sequence 
attached to a functional group aldeyde (CHO), chloromehtylketone (CMK) or fluoromethylketone 
(FMK). Inhibitors of FMK type, such as z-LEHD-FMK and z-IETD-FMK have been chosen as probes of 
biological function for various caspases in vivo. However, these substrates and inhibitors have limited 
specificity towards their corresponding caspases. It was shown that these substrates have overlapping 
activities for different caspases present in a given cell lysate sample (Pereira and Song, 2008). This 
suggests that the use of these commercially available substrates or inhibitors-based methods is not very 
efficient for assessing individual caspases‟ activities. 
2.7.4 Western blot  
Western blot is a very powerful analytical technique to detect a protein of interest from a mixture of 
proteins in a given sample of cell extract. With this technique it is possible to identify and locate proteins 
based on their ability to bind to specific antibodies.  In this method a primary antibody is used, which 
binds to the target protein to be detected. The protein sample is first run in SDS-PAGE. The proteins 
move based on their molecular weight in the gel. After this step, the separated proteins in the gel are then 
transferred electrolytically onto a membrane. This step is called electroblotting. Nitrocellulose or PVDF 
are the most commonly used membranes for this purpose. The proteins transferred onto the membrane are 
then probed with a suitable primary antibody for a specified period of time. The membrane or the blot is 
then incubated with a secondary antibody. This secondary antibody is tagged to a reporter molecule 
producing color which can be detected by a suitable scanner machine. All the apoptotic proteins can be 
detected by western blot method provided that suitable antibodies are available. By assessing the intensity 
of bands for cells collected at different stages of the cell culture, the progress of apoptosis can be tracked. 
2.7.5 DNA laddering assay 
Following this method apoptosis can be characterized based on the typical changes occurring in DNA 
during apoptosis. DNA fragmentation is a hallmark of apoptosis in many mammalian cell types. In the 
later stages of apoptosis, endonucleases, get activated and translocate into the nucleus and cause DNA 
fragmentation and internucleosomal cleavage. These nucleases cleave DNA and produce DNA fragments 
of 180- 200 base-pair. When observed with agarose gel electrophoresis, a characteristic “ladderlike” 
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appearance can be observed. Flow cytometry also can be used to determine the percentage of cells 
undergoing DNA breaks by tagging fluorescent molecules to DNA breaks (Li et al., 1995). 
2.7.6 DIGE (Differential in gel-electrophoresis) and mass spectrometry 
2D differential in gel-electrophoresis is a powerful tool in proteomics that enables accurate analysis of 
differences in protein expression levels between samples. This method is often used for proteome analysis 
of molecules regulating apoptosis (Ibuki et al., 2005; Kumar et al., 2008; Wei et al., 2011).  The protein 
samples are labeled with fluorescent dyes (Cy2, Cy3 and/or Cy5), then combined together before 2-D 
electrophoresis and then subjected to 2-D electrophoresis. These dyes are spectrally distinct allowing the 
co-separation of different labeled samples in the same gel. This ensures that all samples are subjected to 
exactly the same first- and second-dimension electrophoresis running conditions. Thus experimental 
variation or gel-to-gel variation is avoided. 
With this method up to two experimental samples can be studied together. These two different samples 
and an internal standard are run in a single gel. The two different samples are tagged with either Cy3 or 
Cy5 and the internal standard is tagged with Cy2. The internal standard is prepared by mixing together 
equal amounts of each sample in the experiment. By including the internal standard in every gel within an 
experimental series, an accurate analysis of differences in protein expression levels between samples run 
on different gels can be achieved. The gels are then imaged at the excitation wavelengths of each of the 
three dyes. These images are then merged and analyzed for the differences in the protein expression levels 
by using image analysis software. The differentially expressed proteins can then be enzymatically 
digested with trypsin and readily identified using mass spectrometry. Mass Spectrometry techniques such 
as Matrix Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry (MALDI-ToF MS) 
can identify proteins by generating peptide mass fingerprints (PMF) and subsequent database searching. 
2.8 Dynamic modeling of bioprocesses 
Mathematical modeling of biochemical process has always been an essential tool for making predictions 
about the process and for defining optimal operation recipes for cell cultures. There have been several 
mathematical approaches followed for enhancing the understanding and productivity of those 
bioprocesses, ranging from different empirical model to various dynamic models. However, the use of 
empirical models is limited as they often fail to illustrate the physiological significance of processes and 
they are mostly suitable to represent data used for their calibration but less accurate to predict data not 
used for calibration.  
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Popular dynamic modeling approaches involve Boolean descriptions, automata and stochastic, partial or 
ordinary differential equations. (De Jong, 2002; Ventura et al., 2006). 
This thesis focuses on ordinary differential equations (ODEs) based model. ODEs do not capture spatial 
behavior and they are based on the assumption of perfect reactor stirring. State variables progress in a 
continuous and deterministic fashion. A common representation of ODE based model system can be 
described as follow 
   
  
  ̇  ∑     (   )
 
   
                              
where   represents state variable, grouped into a vector     ,         is the stoichiometric matrix 
and        is the flux or rate vector which depends on the current state   and the parameter vector 
    .  
One of the first dynamic models of intracellular mechanisms of apoptosis was developed by Fusseneger. 
It includes most of the aspects of apoptosis phenomena (Fussenegger et al., 2000). This model describes 
several parts of the phenomena by including both pathways of apoptosis i.e. death receptor pathway and 
mitochondrial pathway. The model is able to describe the principle characteristics of process and known 
regulatory mechanisms. Also in other studies (Harrington et al., 2008) apoptosis was modeled by 
considering both pathways. Eissing had developed models based on differential equations which solely 
focused on the extrinsic death receptor pathways (Eissing et al., 2004). Eissing‟s model was formulated to 
show the fast caspase activation kinetics occurring at the single cell level. Using bifurcation analysis it 
was shown that Eissing‟s model was capable of displaying bistable equilibrium behavior. The parameter 
values were taken from the literature.  It was suggested that the model should include IAP (inhibitor of 
apoptosis protein) and BAR (bifunctional apoptosis regulator) for effective regulation of death-receptor-
mediated apoptosis. In another similar study (Sen et al., 2011), bistability in apoptosis model triggered by 
mitochondrial pathway was shown. Several other models based on the extrinsic pathway of apoptosis 
have also been developed (Bentele et al., 2004; Lai and Jackson, 2004; Lavrik et al., 2007; Rangamani 
and Sirovich, 2007). 
Several studies have also been carried out on the modeling of the mitochondrial apoptotic pathway (Bagci 
et al., 2006; Bao and Shi, 2007; Chen et al., 2007b; Chen et al., 2007a; Cui et al., 2008; Hua et al., 2005; 
Huber et al., 2007; Legewie et al., 2006; Nakabayashi and Sasaki, 2006; Rehm et al., 2006; Stucki and 
Simon, 2005). In studies carried out by Rehm et al., (2006) and Hua et al., (2005), the mathematical 
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model was tested with experimental data. In Rehm‟ studies, the model prediction was verified 
qualitatively and quantitatively at single cell level by including the role of XIAP (X-linked-inhibitor-of-
apoptosis-protein) and Smac (second mitochondria-derived activator of caspases) in apoptosis regulation 
in HeLa cancer cells. The same group has also developed software, available through the web, which 
provides a thorough analysis of mitochondrial-mediated-apoptosis pathway regulation (Huber et al., 
2007). This software is able to produce temporal protein profiles, to identify key regulatory proteins and 
to determine critical threshold concentrations required for the execution of apoptosis in HeLa cancer cells 
or other cell types. It also provides model predictions for the validation of experimental results. 
These models were based on single cell level and consisted of various entities/proteins concentrations as 
state variables. It should be understood that the single cell behavior is more diverse than the population 
behavior in cell culture process. Caspase activation is very rapid at the single cell level while in a 
population of cells caspase activation is in general slow since even when triggering of apoptotic stimulus 
to a population of identical cells, generally individual cells die at different time points. Also, since, the 
above models contained various species which cannot be measured, casts less confidence on reliability of 
parameter values. Thus, the reliability and identifiability of these parameters is somewhat in question with 
regard to their confidence interval being large. (The identifiability of parameters is explained in the 
further section).  
A key challenge in formulating models used to describe apoptosis is to calibrate the large number of 
parameters generally present in these models. The reason for this is that the signal transduction pathways 
involved in apoptosis comprise a very large network of reactions. Thus the number of parameters 
involved is usually large compared to the amount of experimental data, leading to models that are 
generally over-parameterized. Thus the identification of parameters for these models is often very 
difficult. Identification of model parameters from data is a fundamental mathematical problem. Model 
parameters have physical significance and therefore it is important to know if it is possible to determine 
their values from the observed data. Addressing the parameters‟ identifiability problem can be also useful 
for determining what needs to be measured to determine the model parameters. If there are limitations on 
what can be measured, this identifiability analysis can at least provide information about the parameters 
that can be reliably identified from the experimental data. For example, Gadkar‟s group (Gadkar et al., 
2005a; Gadkar et al., 2005b) presented an interesting approach to solving the identification problem by 




2.9 Model discrimination 
Selection of a best model among the available models should be decided based on a suitable criterion. 
Sum of squared errors (SSE) may not be the suitable criterion in deciding the best model as different 
models can have different number of parameters. A model containing higher number of parameters 
usually offers better fitting thus having low SSE. Thus, it is required to apply a penalty that with take into 
account the number of parameters.  
AIC (Aikaike information criterion) (Akaike, 1973) is a common model selection criteria that was used in 
the current thesis to choose the best model. This criterion is defined as 
               (2.1) 
Where   is the likelihood function of the model and    is the number of parameters. In the event of least 
squares analysis where the model error is assumed to be independent and normally distributed, the 
criterion is given as  
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Where  ̂   is the variance and   ̂ are the estimated residuals obtained from model fitting and    is the 
sample size. If variances are unequal for different time data points then it is recommended to use 
weighted residuals in place of    ̂. 
Thus given a set of models, a model that has minimum AIC score is chosen. Thus AIC provides the best 
tradeoff between a small SSE with a relatively small number of parameters 
AIC is corrected for the small sample size (Hurvich and Tsai 1989) and is modified to AICc as follows  
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For small sample size AICc is preferred to AIC for model comparison. Also as the sample size becomes 
relatively larger, the behavior of AICc and AIC converges. Thus use of AICc is always recommended 
regardless of the sample size. As a rule of thumb, when the ratio of number of sample size and the number 
of parameters involved in model is less than 40, AICc is preferred to AIC (Burnham and Anderson, 
2004).  
If the AICc scores of the models differ significantly, then we can conclude that one model is  
better than the other.  However, we cannot confidently choose one model over another if the AICc scores 
of those two models are close.  The probability of choosing the correct model based on AICc scores, is 
computed as follows (Motulsky and Christopoulos, 2004), 
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where    is the absolute difference in AICc scores of the two models.  
Thus if the AICc scores of the two models are equal, then the    will be zero, and both the models will 
equally likely to be correct. 
Another criterion used in the current work for comparing candidate models is BIC (Bayesian information 
criterion) (Schwarz, 1978) and defined as 
                ( ) (2.8) 
In the case of independent and normally distributed model error, the criterion reduces to 
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Many of the authors have used these criteria in model selection. It was implemented for model selection 
to describe the data for HIV viral fitness experiments (Miao et al., 2009). Other studies where these 
35 
 
criteria were used include lymphocyte growth regulation (Hawkins et al., 2007), the parotid gland dose-
response relationship (Houweling et al., 2010), in tumor cell growth progression (Zhou et al., 2010). 
2.10 Parameter sensitivity and identifiability 
After modeling a process, analysis should be carried out to assess the model‟s reliability. Since the main 
elements of the model are the parameters that depict aspects of the process, analysis is carried out that 
assesses the reliability of parameters.  One such approach is to assess the identifiability of parameters. 
This is important to carry out to verify how uncertain the parameters in a given developed model are. 
Since the parameters are developed based on given measurements, the reliability of parameters depends 
on the quality of the data obtained. However, the measurements are not always accurate; there will always 
be some error involved in the measurements. These may be due the handling, instruments noise or some 
undetectable environmental factors. The nosier the measurements are and the lower the number of 
sampling data points of measurements is, more uncertain these parameters could be. Therefore the model 
developed with these measurements may not be very accurate and is subjected to some degree of 
uncertainty in the parameters. The parameters for which no unique solution exists have higher degree of 
uncertainty, so cannot be unambiguously determined or are non-identifiable. An identifiability test can be 
implemented for parameters involved in a given model developed. For non-identifiable parameters, their 
confidence interval would be infinite showing that they cannot be estimated from the given available data. 
There are two types of identifiability: theoretical identifiability and practical identifiability. Theoretical 
identifiability investigates if the parameters in the ODE‟s based models are identifiable under the 
assumption of accurate measurement (no measurement noise), while practical identifiability refers to 
parameter whether they are identifiable from noisy experimental measurements. Accordingly, theoretical 
identifiability only depends on the characteristics of the model structure, so it is also referred to as 
structural identifiability analysis. Though structural identifiability analysis is based on the assumption of 
accurate model structure and no measurement noise, which may not be realistic, it is still useful. Because 
of the physical significance of parameters it is crucial to know if it is possible to determine their values 
from measurement information. This analysis can be also useful for experimental design where the 
inverse problem of what needs to be measured to estimate the model parameters has to be solved. 
Identifiability analysis is closely related to sensitivity analysis which examines how sensitive the the 
model response is to a particular parameter if that parameter is varied by some degree. Low sensitivity 
typically corresponds to high variability in the calibrated parameter and it is generally found non-
identifiable by identifiability analysis. 
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If the sensitivities of the responses with respect to parameters are linearly independent, the parameters are 
considered to be identifiable (Beck and Arnold, 1977). Plotting the progression of sensitivity scores with 
respect to time would give the idea of the identifiability of parameters. If the sum of the sensitivity scores 
of two parameters on the same response is zero throughout the time, the parameters are considered to be 
perfectly correlated and cannot be estimated simultaneously.  
There are several methods for estimating parameters as described, for example, in Moles et al., (2003), 
Gadkar et al., (2005a,b), Vayttaden et al., (2004) based on the measurements. In another study, an 
empirical observability Gramian method was proposed for determining identifiability on a model of 
biological system of the NF- B signal transduction pathway (Geffen, 2008). Another approach proposed 
by Yao et al., (2003) uses an orthogonalization procedure to obtain a set of identifiable parameters applied 
to a dynamic reactor model for gas-phase ethylene-butene copolymerization. This approach involves the 
formulation of the sensitivity score matrix as follows 
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where  : state variable,     ,  : parameter vector,     , t: time of sampling,      
  
   
|
     
: The sensitivity score of the      response with respect to     parameter at time   . 
 
This method provides two outcomes: it identifies a set of the estimable parameters and also ranks them 
from the most identifiable to the least one.  Because of the possible existence of strong correlations 
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between the parameters, ranking of parameters is not straightforward. This method starts with finding the 
most identifiable parameter as the one whose corresponding column has the largest magnitude in terms of 
sum of squares. Now, if there exists any correlation between this parameter and the remaining parameters, 
their influences on the response variables are adjusted by orthogonalization of the columns in the   
matrix. This is performed by the following operation  
  ̂    (  
   )
    
   (2.11) 
where,  ̂   is considered as the prediction of the full sensitivity matrix   based on the most identifiable 
parameter and    is the column for the first most identifiable parameter.  
A residual matrix is calculated as  ̂     . The next estimable parameter is then chosen corresponding a 
column which has the largest magnitude in terms of sum of squares in the residual matrix. A column the 
  matrix corresponding to this this second most estimable parameter is then augmented in the matrix    
and is denoted by     . Following operation is then performed to adjust the effect of the second most 
estimable parameter  
  ̂      (    
     )
      
   (2.12) 
This orthogonalization procedure continues until a set value of the sum of squares in the columns of the 
residual matrix corresponding to the remaining parameters is reached.  
The most identifiable parameters correspond to the ones that have a near to unique solution, i.e. their 
variability is very small. The variability in the parameters can be calculated by the Fisher Information 
Matrix as follows 
      ∑ 
    
 
 (2.13) 
where    is the inverse of the covariance matrix of measured output error. The Cramer-Rao bound states 
that the inverse of the FIM represents the error covariance matrix of the minimum variance unbiased 
estimator (Kay, 1993), and thus a lower bound on the variance of the identifiable parameter can be 
obtained from the diagonal of the FIM as 
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   (  )  (   
  )   (2.14) 
Thus the FIM can be considered as a measure of the information on model parameters gained from an 
experiment. The FIM can serve as an important tool for constructing an optimal experimental-design 
using various criteria such as the D-optimality criterion which maximizes the determinant of FIM. This 
optimality criterion involves obtaining maximum information of or equivalently, minimizing the variance 
















Chapter 3  
Materials and methods 
This chapter describes the methods used in thesis work including CHO cell culture experiments for mAb 
production and measurements of various metabolites, nutrients and caspases involved in apoptosis. 
3.1 Cell culture experiments  
This section describes the cell line under study and various experiments performed to quantify cell growth 
and apoptosis.  
3.1.1 Cell culture and media 
A dihydrofolate reductase-deficient CHO (dhfr
- 
CHO) cell line transfected with a fully human IgG-
Variant gene for anti-RhD mAb (IgG1-r9B8)  provided by an industrial partner (Cangene Corporation, 
Mississauga, Ontario) was used in the current study. This recombinant mAb has shown a higher affinity 
for the human RhD antigen, thus makes it suitable for therapeutic application (Wiersma, 2000). 
The cells were grown in serum free SFX-CHO medium (Thermo Scientific HyClone) in batch mode in 
spinner flasks. Since the medium does not contain glutamine (Sigma-Aldrich Chemicals), it was 




3.1.2 Maintenance of cells 
Maintenance of cell bank reserves was carried out by storing the cells in a cryogenic environment. 
Dimethyl sulphoxide (DMSO) was used as a cryoprotective agent.  Initially, a healthy culture with cell 
viability higher than 90% was harvested in the mid-exponential phase of growth and then centrifuged. A 
cryopreservation medium containing 45% fresh medium, 45% conditioned medium and 10% of a 
cryoprotective agent, DMSO was used to re-suspend the cells to a concentration of approximately 1×10
6
 
cells/mL. Serum with a concentration of 2% by volume was also added to the fresh medium. The addition 
of serum helps in improving the post-freezing survival and recovery of the cells. A volume of 1 mL of 
cell suspension in cryopreservation medium was aliquoted into cryovials. These cryovials were then 
incubated overnight in a -80˚C freezer and then immediately placed to a liquid nitrogen storage container 
for long term preservation.   
3.1.3 Revival of cell line 
Revival of cells preserved in a liquid nitrogen tank, was accomplished by thawing a frozen vial of cells in 
a 37˚C water bath for approximately 2 minutes. The vial was swirled gently into the water bath. An anti-
microbial reagent (Acryl AquaClean, WAK–Chemie), used as disinfectant, is added to the water bath to 
avoid any microbial contamination. The vial was removed soon after the contents were thawed and then it 
was kept within a laminar flow hood after decontaminating it with 70% ethanol. The vial contains 
approximately 1x10
6
 cells in 1 mL of growth medium. The cell suspension in the vial was then transferred 
into a 25-cm
2
 T-flask containing approximately 4-5 mL of fresh SFX-CHO medium supplemented with 
2% serum. Prior to the transfer of the cell suspension from the vial, the T-flask containing medium was 
placed in a CO2 incubator (Sanyo IR Sensor, 37˚C, 5% CO2) for sufficient time to attain optimal 
temperature and pH conditions. The T-flask with the cell suspension was then incubated for 1-2 days 
depending on the cell growth. In mid-log phase (usually two or three days), the cells were harvested and 
passaged to another T-flask containing fresh medium every two or three days (i.e. sub-culturing). The 
following method was used: 
1. Initially, all the supernatant was removed from T-flask. A dissociating agent TrypLE (Invitrogen) 
was added to the flask at a ratio of 1 mL to 20 mL of medium of T-flask used in the previous 
passage for culturing.  
2. The flask was then gently shaken for a few seconds so that TrypLE covers all the surface area of 
the bottom of flask covering all the cells.  
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3. The flask was then incubated at 37 °C for approximately 5 minutes. This incubation facilitates 
cell dispersal and so reduces the enzyme exposure period relative to that when kept without 
incubation at 37
o
 C. Cell detachment was confirmed by observing the flask under an inverted 
phase-contrast microscope.  
4. After the complete detachment of cells was observed, 5 mL of fresh medium and 5mL of spent 
medium, i.e. a total 10 mL of medium, was added to the flask. The spent medium was added to 
supplement the next sub-culture with the components which cells might have previously 
produced for cell growth during the course of the cell culture. 
5. The cells were mixed homogeneously by aspirating through gentle pipetting. Inactivation or 
removal of TrypLE by centrifugation was not required as TrypLE has a gentle effect on cells and 
its concentration is negligible after dilution.  
6. Approximately 1 mL of cell sample was removed by pipette and transferred to an eppendorf to 
count the cells. Cell concentration was then measured by a hemocytometer.  
7. Based on cell concentration, a new subculture was prepared with a cell concentration of 0.2x106 
cells/mL. The original serum concentration in the flask (2%) was gradually reduced to 0.5% or 
less during the following subculturing steps. 
3.1.4  Culturing in spinner flask as suspension culture 
The cells were cultured in spinner flasks as suspension cultures for further experiments. For this purpose, 
the cells were adapted to suspension culture before starting the experiments in spinner flask by growing 
them in suspension in smaller volumes (starting from 80 mL to 250 mL) in a 250 mL spinner flask and 
then scaled up to 500 mL culture volumes in 500 mL spinner flask. A trypsinized monolayer culture from 
T-flask was seeded with a final cell concentration of (0.1-0.3) x10
6 
viable cells/mL in the spinner flask. 
The culture was agitated at 100 RPM stirring speed. The agitation rate of 100 RPM was same throughout 
all the experiments. A 4-position magnetic stirrer was installed inside the CO2 incubator to provide 
agitation. Being inside the incubator, the spinners were maintained at the conditions of temperature, 
humidity and CO2 atmosphere as that used for T-flask cultures. The viable cell concentration and viability 
was checked every 2-3 days. At the beginning the serum level was kept at 2% depending on the growth of 
suspension culture and then it was gradually reduced to 1% after the growth rate stabilized to suitable 
levels.   
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3.2 Monitoring of cell culture 
Samples were taken at different time points during the cell culture and analyzed for viable cell 
concentration, viability, apoptosis, nutrient, metabolites etc. These assays are described below. 
3.2.1 Cell count and viability measurement  
     Samples were taken at regular time intervals. The cell density was determined using a hemocytometer. 
Cell concentration and viability was determined by the trypan-blue dye exclusion method (Phillips, 1973). 
In this method, trypan blue dye is used to estimate viability by distinguishing viable from dead cells. The 
dye is used at a concentration of 0.5% mixed in PBS. This dye can only diffuse through membranes of 
nonviable cells, making them appear blue. A 100μL sample was taken from the cell suspension in 
eppendorf and diluted in 1:1 with trypan blue dye. The stained cells were counted within 3 minutes of the 
addition of the trypan blue to the cell sample with the hemocytometer positioned under a light 
microscope. The viability of cells was quantified by the ratio of viable cell count to total cell count. 
3.2.2 Caspase assay 
Samples from the spinner flask cultures were also taken for flow cytometry analysis of caspases.  
Progression of apoptosis in the culture was tracked via flow cytometric analysis of caspases using an 
apoptosis detection kit (Immunochemistry Technology, LLC). The detection is based on a fluorescent 
inhibitor of caspases (FLICA
TM
) methodology. Altogether four caspase assays were used:  a green 
(carboxyfluorescein) FLICA caspase-8 assay kit, a green FLICA caspase-9 assay kit, a red 
(sulforhodamine) FLICA Caspase-3 & 7 kit and a red (sulforhodamine) FLICA caspase-9 assay kit 
(ImmunoChemistry Technologies, LLC). (Caspase-7 is not considered in this study, since it is not as 
widely studied as caspase-3).  The FLICA reagent was supplied as 150X. Before conducting flow 
cytometry analysis, the cells were treated with FLICA reagent. The cells were treated as per the 
instructions provided with the kit. 
Flow cytometry analysis was set up by inducing apoptosis in an exponentially growing culture. 
Staurosporine, a protein kinase inhibitor, has been the most frequently used reagent in vitro to induce 
apoptosis in different cell types.  This reagent is widely known to induce apoptosis via caspase-9 
activation (Chattopadhyay et al., 2011; Manns et al., 2011; Zhang et al., 2004). In addition metal-based 
reagents are also available which can induce apoptosis in cells. Nickel acetate has also been widely 
reported to induce apoptosis via caspase-9 activation (Cai et al., 2010; Dally and Hartwig, 1997; Shiao et 
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al., 1998). It is also reported to induce apoptosis via caspase-8 activation when used in a concentration of 
320µM (Kim et al., 2002). 
In this study, staurosporine was used to induce apoptosis in culture for calibration of flow cytometry 
method. It was used at a concentration of 1µM and then the culture was incubated for around 2 hrs. 
Nickel acetate (II) was also used to treat cells to make sure apoptosis was induced via caspase-8 
activation. It was used at a concentration of 320µM as used by Kim, et al., (2002). The treated culture was 
then incubated for around 12 hours. 
After incubation the cells were subjected to flow cytometry analysis of caspases. The following samples 
were prepared for setting up the method 
1. unstained cells (treated and untreated) 
2. cells stained with only (green) caspase-8 FLICA reagent (treated and untreated) 
3. cells stained with only (green) caspase-9 FLICA reagent (treated and untreated) 
4. cells stained with only (red) caspase-3  FLICA reagent (treated and untreated) 
5. cells stained with only (red) caspase-9  FLICA reagent (treated and untreated) 
6. cells stained with both (green) caspase-8 and (red) caspase-3 FLICA reagent (treated and untreated) 
7. cells stained with both (green) caspase-9 and (red) caspase-3 FLICA reagent (treated and untreated) 
8. cells stained with both (green) caspase-8 and (red) caspase-9 FLICA reagent (treated and untreated) 
The above samples were prepared as per the instructions provided with the kit as described below 
An amount of 0.3x10
6
 cells were taken for the analysis. Since the FLICA should be used as 30X, it was 
diluted to 30X with PBS. An amount of 10µL of this 30X FLICA was added to the cell sample. Cells 
were mixed (by flicking) so that the FLICA was distributed uniformly throughout the sample. The tubes 
containing this sample were then incubated at 37
0
C and 5% CO2 for 45 min in the incubator and protected 
from light. Since the cells might settle during incubation, the tubes were flicked twice during this period, 
after every 15 min. At the end of incubation period, the cells were washed twice with wash buffer 
provided with the kit. Finally, after centrifugation, the cells were suspended into 400µL of wash buffer 
and analyzed by a flow cytometer (BD FACSVantage SE). For each sample, the fluorescence of 25,000 
cells (events) was measured on a flow cytometer. Data were acquired
 
and analyzed using the WinMDI 2.9 
software (The Scripps Research Institute, CA, USA). 
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3.2.3 Western blot 
This analytical technique was used for the analysis of death ligand proteins suspected to be involved in 
the extrinsic pathway of apoptosis. Analysis of these ligand proteins is necessary as it can provide 
important information on the onset of apoptosis and this information could be potentially included as an 
input into the mathematical model. FASL, which is a transmembrane protein, is a widely studied ligand 
protein in the death-receptor-mediated (extrinsic) apoptotic pathway. Therefore western blot was carried 
out for both the detection of FASL and caspases. Since there are no CHO specific primary antibodies 
available, the success of western blot to detect these proteins was questionable. Consequently, a number 
of trials were done to confirm the presence of these proteins in the CHO culture samples. Some primary 
antibodies are available from mouse or human, which as per the manufacturers‟ explanations can detect 
mouse, rat and human version proteins. Different antibodies were tried until successful detection of FASL 
was obtained. A procedure was developed and is described below 
3.2.3.1 Cell lysis 
Cells samples were collected at different times from the spinner flask for western blot analysis. After 
sampling, cells were first washed twice with cold PBS (at approximately 4
0
C) then stored at -80
0
C until 
analyzed. The cell lysis was carried out on ice. Approximately 10 µL of lysis buffer per 1x10
6
 cells was 
used. An inhibitor cocktail mix (Sigma Chemicals) was also added to avoid any inhibition of proteins 
which might occur during the lysis process. This inhibitor mix was added to the cell sample before adding 
the lysis buffer. An amount of 1 µL of inhibitor mix per 1x10
6
 cells was used. After adding the lysis 
buffer and inhibitor mix, the cell sample was mixed well. The cells get lysed during this time. The sample 
was then centrifuged for 10 min at 14000 RPM, sufficient time to obtain a clear supernatant (cell lysate). 
The supernatant obtained was then used for western blot analysis. 
3.2.3.2 SDS-PAGE gel electrophoresis 
For western blot analysis, proteins were separated using SDS-PAGE. 25 mL of 12% polyacrylamide gel 
was used for SDS-PAGE analysis. Cell lysate proteins were loaded into the wells of the SDS-PAGE gel 
using loading tips and then run with pre-stained protein molecular weight marker. Electrophoresis was 





12% Polyacrylamide Running gel (25 mL) 
Component Volume (mL) 
Water 8.2 
30% acrylamide 10 
1.5M Tris (pH 8.8) 6.3 
10% SDS 0.25 
10% ammonium persulfate 0.25 
TEMED 0.01 
And the stacking gel (5 mL):  
Component Volume (mL) 
Water 3.4 
30% acrylamide 0.83 
1.0M Tris (pH 6.8) 0.63 
10% SDS 0.05 
10% ammonium persulfate 0.05 
TEMED 0.005 
 
3.2.3.3 Protein transfer 
After electrophoresis was complete, the transfer of protein was carried out. For this purpose a 
nitrocellulose membrane was used. The transfer assembly, including sponges and blots, was soaked in 
transfer buffer. The composition of the transfer buffer was as follows 
 
Component Composition 
Glycine 192 mM 





The gel was then sandwiched into the transfer cassette as shown in Figure 3.1. The cassette was then 
arranged into the transfer tank and then transfer/electroblotting was carried out at a constant voltage   of 
30 V overnight in a cold room.  
3.2.3.4 Blot analysis by antibodies 
After transfer, the membrane was then washed with water on a rocker for about 10 min.  Ponceau staining 
was used to check the success of the transfer. Following the staining of the membrane, it is possible to cut 
the membrane into horizontal strips of individual samples to investigate the properties of different sizes of 
proteins on the same membrane. This stain can then be removed with 1X TBST (Tris Buffered Saline 
with Twen-20)  made from 10X TBS (Tris Buffered Saline) with the following composition 
 
10X TBS Components Composition  1X TBST (1L) Components Volume 
 Tris-HCl pH 7.6 200 mM   10X TBS 100 mL 
 NaCl 2.0 M   20% Tween 5 mL 
     Make up to 1 L  
 
 
Black side of cassette Cathode 
Sponge  
Blotting paper  
Gel  
Membrane  
Blotting paper  
Sponge  
White side of cassette Anode 
 
Figure 3.1: Assembly of Western blot transfer cassette 
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After destaining, the blot or membrane was subjected to blocking with 3% Bovine serum albmin (BSA). 
(BSA was made in 1X TBST and this solution was filtered before using it for blocking). Blocking was 
done for 2 hrs at room temperature. Blots were then probed with 1:200 dilution of rabbit polyclonal 
primary antibody (Santacruz Biotechnology, 200 µg/mL) and incubated for either 2 hrs at room 
temperature or overnight at 4
0
C.  
The washing of the blot was done with 1X TBST after primary antibody incubation. The blot was rinsed 
twice with two changes of 1X TBST and then washed for 5 min for three times with fresh changes of 1X 
TBST. After these washing steps, the blot was incubated with 1:25000 dilution of an HRP labeled anti-
rabbit secondary antibody for 1 hr at room temperature. Washing was done in the same way as done after 
the primary antibody incubation. After this step, the detection was carried out in a dark environment using 
an enzyme linked chemiluminescence plus detection reagent (ECL Plus: GE healthcare, USA). The 
detection solutions A and B were mixed in a ratio of 40:1 to provide an amount that is sufficient for 
covering the blot at 0.1 mL/cm
2
. The membrane was then exposed to this detection mixture for about 5 
min and then the blot was scanned with a Typhoon9400 scanner (GE healthcare, USA). 
3.2.4 Monoclonal antibody assay 
The Enzyme-Linked Immunosorbent Assay (ELISA) was used for the measurement of total human IgG1 
antibody concentration in cell culture samples. The method developed by Cangene for this IgG1 was used 
in this study. A goat anti-human IgG (Jackson ImmunoResearch Laboratories, Inc.)  was used as primary 
antibody and alkaline-phosphatase conjugated goat-anti-human IgG (Jackson ImmunoResearch 
Laboratories, Inc.) was used as secondary antibody. A substrate used for alkaline-phosphatase was p-
nitro-phenyl (Sigma Aldrich Ltd.). The assay was performed in 96-well flat-bottom microtiter plates 
(Immulon
®
 2HB). Human IgG1 myeloma (Calbiochem) was used as standard. Various dilutions of 
standard were made to construct standard curve of absorbance to quantify the amount of IgG1 in cell 
culture samples. The absorbance was measured at 405 nm in a spectrophotometer (DU 520 UV/Vis, 
Beckman Coulter).  
3.2.5 Glucose assay 
Glucose in cell culture samples was measured by an enzymatic method using a glucose kit (Megazyme 
Glucose Test Kit) according to provided directions. The assay is based on the glucose oxidase/peroxidase 
reactions. Glucose determination reagent provided with the kit was added to the sample and the mixture 
was then incubated for 20 min at 40°C. The absorbance of the assay mixture was read at 510 nm against 
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the reagent blank. The color intensity of the dye produced after the reaction period is proportional to 
glucose concentration.   
3.2.6 Lactate assay 
Lactate assay was performed by using lactate strips in a Lactate Plus meter (Nova Biomedical, USA). In 
this method, the strip is dipped into a drop of sample. The meter reads the concentration of lactate in the 
sample.  The meter contains a lactate oxidase biosensor with a measurement range of 0.3-25 mmol/L. 
3.2.7 Amino acid assay 
Amino acids in cell culture samples were assayed by high-performance reverse-phase chromatography. 
The pre-column derivatization technique using phenylisothiocyanate (PITC) was employed to analyze the 
free amino acids in culture. The method involves  reaction of PITC with amino acids forming  
phenylthiocarbamyl (PTC) amino acid derivatives (Bidlingmeyer et al., 1984) which can be detected by 
ultraviolet absorbance. The derivatization reaction is shown in Appendix A. The method started with 
drying of samples and standard amino acids solutions (Sigma-Aldrich Chemicals) under vacuum. A 
volume of 10μL sample and standard amino acid solutions at a concentration of 2.5 μmol/mL was used in 
micro-centrifuge tubes for drying. This was followed by addition of 20 μL of solution of ethanol, water 
and triethylamine (TEA) in the ratio of 2:2:1 respectively. The samples were dried again under vacuum. A 
freshly prepared derivatization reagent (solution of ethanol, TEA, water and PITC in the ratio of 7:1:1:1 
respectively) was added to the dried samples. PITC is unstable in air, so this addition was performed in a 
nitrogen environment. A volume of 20 μL of this derivatization reagent was added to the samples to 
obtain the PTC-amino acids derivatives. These samples were then incubated sealed for 20 min at room 
temperature. After completion of reaction period of 20 min, the samples were subjected to vacuum drying 
to remove any un-reacted reagent. After the completion of drying, the derivatized samples could be stored 
dry and frozen without significant degradation.   
Before HPLC analysis, the dried derivatized samples and amino acid standards at various dilutions were 
then dissolved in 500 μL of mixture of 50mM sodium acetate, pH 6.35 (containing 400µL of TEA per 
liter of buffer) and acetonitrile (ACN). These standards at various dilutions were used for constructing the 
calibration curve. The chromatography system was a Varian ProStar reverse phase HPLC (Varian 
analytical Instruments, USA). Eclips Plus C18 column (150×4.6 mm, I.D.) was used for separation. A 
volume of 10 μL of each sample and standards was subsequently injected into the column using an 
autosampler. The column was maintained at 40˚C and the UV detector was set at 254 nm. The solvent 
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system consisted of two eluents: Solvent A, an aqueous buffer, was 50mM sodium acetate containing 0.4 
mL/L TEA which titrated to pH 6.35 using glacial acetic acid and Solvent B was a 60% solution of 
acetonitrile in water.  The two eluents were run at a flow rate of 1.0 mL/min. A gradient mixer of solvent 
system adopted by Gheshlaghi et al., (2008) was used optimal separation of amino acids. This gradient 
profile consisted of starting the run with a 90% A / 10% B solution and then gradually changing the 
concentration to 49% A  / 51% B. This gradient was set for a period of 20 min, followed by the injection 
of a 100% B solution to flush the column to remove any residual sample component from it. 
3.2.8 Ammonia assay 
The dissolved ammonia concentration in cell culture samples was measured with an Ammonia Ion-
Selective electrode (VWR) using a pH/ISE meter model 710A. The electrode contains a hydrophobic gas-
permeable membrane that separates the sample solution from an electrode internal standard solution of 
ammonium chloride. The method involved increasing the pH of sample above 11 with an ionic strength 
adjustor (ISA) also called alkaline reagent. 10M NaOH solution was used as an alkaline reagent (ISA) 
and was added to the sample solution just before the measurement was taken. A volume of 10 µL of ISA 
was added to 1 mL volume of cell culture sample for ammonia measurement. This converts the dissolved 
ammonium in the sample to the gaseous form (NH3), which then diffuses through the electrode membrane 
until the partial pressure of ammonia will be proportional to its concentration. The resulting change in the 
pH of internal solution is measured by the pH electrode. Calibration curve was prepared by using standard 
ammonia solutions (NH4Cl) with known concentrations.  
3.2.9 Dissolved oxygen (DO) assay 
A VWR symphony Dissolved Oxygen probes designed for use with VWR symphony series Dissolved 
Oxygen Meters was used to measure DO in cell culture samples. The electrode calibration (one point 








Chapter 4  




This part of the work involved investigating different factors that trigger apoptosis in the CHO cell line 
under study. The TNF super-family members such as FASL and TNF-, as mentioned in Section 2.5.1 
are responsible, for triggering the extrinsic apoptosis pathway by cell-cell interaction. Initially, a 
qualitative analysis of death ligand proteins by western blot was carried out to test whether these proteins 
are responsible for triggering the death-receptor-mediated apoptotic pathway in CHO cell cultures. After a 
number of preliminary unsuccessful trials with different primary and secondary antibodies, a primary   
antibody (rabbit polyclonal from Santa Cruz Biotechnology, USA) and secondary antibody (ECL plus, 
GE Healthcare) antibody led to relatively successful identification. The result obtained by using these 
antibodies for the detection of FASL is shown in Figure 4.1. From comparison to the marker protein 
bands it was found that the band observed in the blot corresponds to ~40kD which is the approximate 
molecular weight reported for FASL. This seems to confirm the presence of FASL protein in the cell 
culture thus indicating activation of the extrinsic apoptotic pathway. This result was obtained by 
incubating the membrane with primary antibody for two hours. The result was also corroborated by 
subjecting the membrane to overnight primary antibody incubation.  
Although the correct band was found, the band clarity was not well defined because of background and 
non-specific binding. Thus the technique needs further improvement to reduce this background and non-
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specific binding that was observed on the membrane. By decreasing this background, the signal-to-noise 
ratio could be increased. Improvements could be achieved by decreasing the blocking time, and by 
varying the concentrations of the primary or secondary antibodies. A well-defined band with a high 
signal-to-noise ratio is necessary if densitometry measurements, for the quantification of protein through 
intensity measurement, are to be carried out. 
This result, which suggests the presence of FASL in the CHO cell culture, is important evidence of the 






Figure 4.1: Western blot analysis of FASL (A) Marker (B) sample incubated with primary antibody 
 for 2 hrs (C) sample incubated overnight with primary antibody 
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Since FASL could not be satisfactorily detected from western blot experiments with higher signal-to-
noise ratio sufficient for quantification, it was proposed to investigate the effects of cell density on 
apoptosis based on the premise that higher density may be directly related to cell-cell interaction due to 
cell proximity and higher release into the medium of proteins involved in cell-cell interactions. In 
previous reports, cell density has been found to be a trigger for inducing apoptosis in cell culture via cell-
cell communication (Ishizaki et al., 1994; Mathieu et al., 1995; Saeki et al., 1997). Cell density could also 
lead to apoptosis as a result of nutrient depletion occurring in high density cultures. However, it was 
found in an earlier work by our group (Naderi et al., 2011), by experimenting  with varying 
concentrations of glutamine, glucose or with concentrated media, that growth arrest or apoptosis are not 
significantly correlated with nutrient limitations in the CHO cell culture used in this study. Then, having 
found that apoptosis was not correlated to nutrient limitations, experiments were designed to investigate 
both the density effect and correlations between apoptosis and the accumulation of toxic metabolites, such 
as ammonia, that have been reported to trigger the intrinsic apoptotic pathway (Lao and Toth, 1997; 
Ozturk et al., 1992). 
4.2 Materials and methods 
4.2.1 Cell culture and experimental design 
Each set of batch cultures with working volume of 500 mL was carried out in 500 mL spinner flasks in a 
humidified incubator at 37
◦
C with 5% CO2 and agitated at 100 rpm on a magnetic stirrer inside the 
incubator. Each spinner flask was inoculated with a common seed culture. Regular, daily sampling was 
performed to assess cell growth, viability, apoptosis and metabolite analysis. HyClone SFX-CHO 
medium was the basal medium used to perform sub-culturing and to perform the final growth 
experiments. Batch cultures were set up in four 500 mL spinner flasks, labeled SP1, SP2, SP3 and SP4, 
with different initial cell densities out of common seed culture. The preparation of this common seed 
culture is described as follows 
 Two cultures of 500 mL volumes were grown each separately in 500 mL capacity spinner flasks and 
one of 1000 mL volume in a 1000 mL capacity spinner flask.  
 The cultures, during the exponential phase, were harvested and added in a separate 2000 mL 
sterilized vessel with 50 mL pipette. Since only the pipette of maximum capacity available was 50 
mL, it was used to mix the whole culture by aspirating in and out. This was performed till 
homogeneity of seed culture is assured.  
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 Individual volumes of 50 mL of seed culture were pipetted out from the 2 liter vessel into separate 
50 mL centrifuge tubes.  
 The tubes were centrifuged at 300 g for 5 min. After centrifugation, supernatant was removed and 
then fresh SFX-CHO medium was added to each tube to suspend the cells remained at bottom after 
centrifugation. The suspension was mixed homogenously by aspirating in and out with a 25 mL 
pipette. The well mixed suspension from each tube was then added to the respective spinner flasks 
(SP1-SP4) in quantities as required to achieve the desired initial cell densities. Additionally, the 
tubes were rinsed with some more fresh medium to suspend leftover cells. This suspension was 
added again to spinner flask to avoid the loss of cells.  








 cells/mL cell 
concentrations respectively but the actual initial concentrations (reported below) were slightly different. 
For each batch culture a calculated volume of seed culture, according to the above mentioned initial cell 
density, was centrifuged, supernatant was discarded and the settled cells were then suspended in fresh 
medium in the corresponding spinners. Then, after seeding the spinners the medium in each spinner was 
supplemented with serum and glutamine, with different concentrations according to the initial cell density 
used in each particular spinner. The lowest cell density culture spinner (SP1) was supplemented with 1% 
serum and 1mM glutamine. The same initial ratios of serum and glutamine per cell were provided in the 
remaining three spinner flasks (SP2-4) to avoid the possibility of nutrient depletion in higher–cell-density 
spinners. For instance, the concentration of serum and glutamine was four-fold higher in the highest cell 
density culture (SP4) compared to the lowest cell density culture (SP1) but the ratio between glutamine to 
serum was maintained the same in the four spinners. 









 cells/mL respectively, were slightly different from the projected values due to 





cells/mL were originally designed as replicates. The actual initial cell 
concentrations deviated from the projected ones. This deviation can be attributed to the insufficient 
centrifugation (300 g for 5 min) due to which the cells might have lost in the supernatant. It can also be 
attributed to the loss by possible removal of cells from the settled clump of cells along with the removal 





4.2.2 Caspase assay 
The caspase assay was performed by flow cytometry by measuring intracellular caspase activity levels. 
The FLICA based methodology (Immunochemistry Technology, LLC) was used for this purpose.  
Altogether four caspase assays were used:  a green (carboxyfluorescein) FLICA caspase-8 assay kit, a 
green FLICA caspase-9 assay kit, a red (sulforhodamine) FLICA Caspase-3 & 7 kit and a red 
(sulforhodamine) FLICA caspase-9 assay kit (Caspase-7 is not considered in this study, since it is not as 
widely studied as caspase-3). Flow-cytometry analyses began approximately 1 day after seeding at which 
time the cultures had entered exponential phase. For each spinner flask, three aliquots were collected at 
each time point.  One was tested for levels of caspase-8 and caspase-3 activation, the second for activated 
caspase-9 and caspase-3 and the third for caspase-8 and caspase-9 activation. Although the simultaneous 
testing of all three caspases would be preferred, no such three channel assay is currently commercially 
available. For each sample, the fluorescence of 25,000 cells (events) was measured on a flow cytometer 
(Becton Dickinson FACS Vantage SE). Analyses of flow cytometry data were performed using WinMDI 
v2.9 (Scripps Research Institute, CA, USA).  To classify cells based on their caspase activation status, 
intensity thresholds for each caspase were set by single-dye negative controls prepared at day one. For 

















































.  The experimental results showed that whenever cells were positive for caspase-3, 








 subpopulations were 
negligible. This is likely a result of cross-talk between the two pathways. A population-based model 
describing the progression of caspases over time and its correlation to apoptosis from these experimental 
observations was developed as described in Chapter 5. 
4.3 Results and discussion 
Figure 4.2 shows the changes of viable cell concentration over time for the four batch experiments with 
different initial concentrations as described above.  For the lowest initial cell density culture (SP1), a lag 
phase is clearly noticeable. The cells may exhibit extended G1 phase or temporarily enter into G0 phase 
during this lag period. On the other hand there is no observable lag in the higher cell density cultures. The 
observed lag phase in the low initial cell density culture can be attributed to higher magnitude of growth 
factors (auto-stimulatory compounds released into medium) reduction following medium dilution after 
inoculation as opposed to higher cell density cultures (SP2-4). Thus it can be interpreted that in the high 
initial cell density, cultures overcome a limiting value of growth factors that is required for continued 
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exponential growth of cultures. It can be also seen in Figure 4.2 that the viable cell concentration in SP4 
reaches more rapidly its maximum as compared to the other cultures, but also declines more rapidly. Cell 
growth was assessed determining specific growth rate (Table 4.1) which was calculated as average 
quantity during the exponential growth phase. Since it is not possible to accurately separate the two 
phases of growth i.e. exponential and stationary phase, the numbers are approximate. It was found that the 
average specific growth rate was inversely correlated to the initial cell density (Table 4.1). Thus, the 
specific growth rate was higher in the lower initial cell density culture and it decreased as the initial cell 
density increased. Similar observations have been reported for hybridoma batch cultures in T-flask where 
the specific growth rate increased for increasing initial cell densities up to a certain initial cell density 
value and then decreased beyond that critical value (Lee, 2000). Regardless of the differences in growth 
rates, the maximum cell density values were similar for the higher initial cell density cultures (SP4, SP2 
and SP3), though these peak concentrations were reached at different times. On the other hand, significant 
differences were observed in terms of nutrient depletion and metabolite production rates. These rates were 
calculated as average quantities throughout the whole culture period from the slope of the plot of nutrient 
/metabolites/product concentration vs. time integral of viable cells. Since lactate production remained 
constant after certain period of culture, its specific production rate was calculated only upto the period 
where its production starts becoming constant. The procedure for calculation of these rates is shown in 
Appendix B. The specific glucose consumption rate (    ) in the lowest initial cell density culture was 
significantly higher than for the highest initial cell density cultures (Table 4.2). Figure 4.3 shows the 
progression with time of glucose, lactate, glutamine, and ammonia concentrations in the four spinners. As 
shown in this figure, when the viable cell concentration maxima were reached, neither glucose nor 
glutamine was completely depleted suggesting that they were not limiting growth. From Table 4.2, it can 
be observed that the specific glucose consumption rate was lowest in highest initial cell density culture 
(SP4), while it was highest in lowest initial cell density culture (SP1). This can be attributed to the 
specific growth rates in these cultures: the specific glucose consumption rate was higher in higher specific 
growth rate cultures and lower in lower specific growth rate cultures.  Similar observation can be made 
with other cultures (SP2 and SP3) where the glucose consumption rates were lower than in the lower 
initial cell density culture SP1. The same interpretation can also be made with specific lactate production 
rate (    ) which was also correlated to the specific growth rate, i.e. higher in the higher specific growth 
rate culture and lower in lower specific growth rate culture. Similar observations have been reported for 
hybridoma in perfusion culture where it was found that specific glucose consumption and specific lactate 











Table 4.1: Average specific growth rates in different initial cell density cultures 
 
 SP1 SP2 SP3 SP4 









Average specific growth rate (day 
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Table 4.2: Specific glucose uptake (    ) and lactate production rates (    ) in different initial cell 
density culture 
 
 SP1 SP2 SP3 SP4 




1.48 1.07 1.15 0.9 
 



















In a parallel investigation to the current one (Naderi, 2011) the evolution of apoptosis was monitored by 
tracking morphological cell changes characteristic of apoptosis using fluorescence microscopy with 
ethidium bromide (EB) and acridine orange (AO) as markers. It was found that there were relatively few 
necrotic cells (appearing red and round in fluorescence images) and their number did not increase 
significantly with time. Figure 4.4 shows a fluorescence microscopic image of the current CHO cell 
culture in stationary phase obtained with dual staining of ethidium bromide and acridine orange, showing 
the difference between apoptotic dead cells, which were abundant, and necrotic dead cells ,which occur in 
smaller amounts. Thus, that work confirmed that most of the cell death occurs by apoptosis rather than by 
necrosis. 
In addition apoptosis was also monitored based on flow-cytometry scattering parameters. Forward scatter 
(FSC) characterizes cell size whereas side scatter (SSC) characterizes granularity in cell structure. When a 
cell becomes apoptotic its size decreases.  Consequently FSC decreases during this change while SSC 
remains constant or increases. Figure 4.5 shows characteristic flow cytometry forward scatter-side scatter 
(FSC-SSC) plots in the low initial cell density culture (SP1). The distribution in the plot indicates 
subpopulations involving cells that decrease in size thus resulting in a decrease in FSC and an increase in 
SSC indicating the initiation of apoptosis. According to these flow cytometry measurements apoptosis 
appears to become significant after the exponential phase (after day 3) in this culture).  Figure 4.6 shows, 
based on flow cytometry measurements, that the degree of apoptosis was more significant in the high cell 
density culture SP4 than in the low cell density culture SP1 (~45% at day 7 and day 11). 
Necrosis is often associated to cells swelling, leading to an increase in FSC and a decrease in the SSC 
signal. As can be seen from Figures 4.5 and 4.6, there was only a very small increase in FSC.  This 
indicated that there was negligible necrosis in the CHO cell culture system under investigation, 
confirming the aforementioned results obtained by fluorescence microscopy with ethidium bromide and 
acridine orange (Figure 4.4). 
Figures 4.7 and 4.8 show bivariate distributions of fluorescence intensities of green and red FLICA 
markers stained for caspase-8 and caspase-3 in spinner SP1 (low initial cell density culture) and spinner 
SP4 (high initial cell density culture) respectively. The dual color fluorescence data are displayed as dot-
plots of log intensity of green fluorescence of caspase-8 on the x-axis and red fluorescence of caspase-3 
on the y-axis. This dot-plot was sub-divided into four quadrants, corresponding to four cell-





), the lower right quadrant represents cells that are active for caspase-8 but 




), the upper right quadrant represents cells that show simultaneous 
59 
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As the culture proceeded, there was an increase in the amount of data 
points in the lower right and upper right quadrants indicating a corresponding increase in activation of 
caspase-3 which is the executioner caspase at the end of the apoptotic pathways. Also, based on Figures 
4.6 and 4.7, it is possible to infer that there was a larger proportion of apoptotic cells in the high cell 
density culture SP4 as compared to the lower initial cell density culture SP1.  
The degree of apoptosis, quantified by percentages of the total amount of cells passed through the flow 
cytometer (25,000 cells), was obtained from each quadrant corresponding to each subpopulation in the 
above plots. Using these percentages, the evolutions of the caspase-8, caspase-9 and caspase-3 
subpopulations in each of the spinners were determined (Figures 4.9-11). Based on the definition of the 
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) should be identical since both represent the total population of C3
+
.  However, 
these subpopulations were slightly different due to experimental error caused by the calibration of the 
thresholds used to separate the different subpopulations and therefore the average was taken.  
In general, Figures 4.9 to 4.11 shows that caspase activation is correlated to initial cell density, i.e. higher 
initial cell density corresponds to higher caspases‟ activation.  However, it should be pointed out that the 
dynamics of apoptosis in the culture, as quantified by monitoring the evolution of these cell sub-
populations, is significantly different compared to the evolution of apoptosis in individual cells.  In a 
culture of cells, a slow gradual activation of caspases along several days is observed but this reflects an 
average over many cells each at different stage of apoptosis. In contrast, caspase activation at the cell 











Figure 4.4: Fluorescence micrograph of CHO cell culture obtained with dual staining of ethidium 
bromide and acridine orange (A) Different physiological states: (a) Normal Viable cells (b) Early 
apoptotic cells (c) late apoptotic cells (approaching death) (d) Dead cells resulting from apoptosis (the cell 








Figure 4.5: Bivariate distributions of cell samples for SSC vs. FSC in the low cell density culture SP1 










Figure 4.6: Bivariate distributions of cell samples for SSC vs. FSC in the high cell density culture SP4 









Figure 4.7: Dual fluorescence staining flow cytometric analysis of simultaneous caspase-8 and caspase-3 
activation in CHO cell culture in the low cell density culture SP1. The four quadrants represent different 
subpopulations based on caspase-8 and caspase-3 activity. The four scatter diagrams show caspase 
activation during the culture  (A) day 1  (B) day 3   (C) day 7   (D) day 11. As the culture proceeds, the 








Figure 4.8: Dual fluorescence staining flow cytometric analysis of simultaneous caspase-8 and caspase-3 
activation in CHO cell culture in the high cell density culture SP4. The four quadrants represent different 
subpopulations based on caspase-8 and caspase-3 activity. The four scatter diagrams show caspase 






Figure 4.9: Caspase-8 subpopulation progression in different initial cell density culture 
 
 














Chapter 5  
Modeling the progression of apoptosis 
Based on the experimental observations in different initial cell density cultures a population-based model 
was developed to describe the dynamic evolution of the different apoptotic subpopulations identified by 
flow cytometry. 
5.1 Materials and methods 
The lowest initial cell density culture (SP1) and highest initial cell density culture (SP4) were used for 
calibrating the apoptosis population-based model. The details of these cultures are given in the previous 
chapter (Chapter 4). The prediction capability of this model was assessed by validating this model against 
data from the remaining two spinner flasks SP2 and SP3 and four additional experiments with different 
operating conditions. The operating conditions of these four additional experiments are given in Table 
5.1.  
5.1.1 Model development 
A subpopulation balance based model was developed to describe the evolution with time of the different 
subpopulations identified in the flow cytometry experiments described in Chapter 4 corresponding to 
different combinations of activated caspases. The estimate of each subpopulation obtained in percentages 
from in each quadrant after dot-plot analysis of flow cytometry results was transformed to concentration 
with corresponding viable cell concentration (  ) obtained using the trypan blue method.  
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Since the specific dependencies of caspase activations with respect to factors such as cell density, 
nutrients‟ levels and toxicants‟ concentration were not known a priori it was decided to formulate a 
number of different model structures that assume different functionalities of caspase activation with 
respect to the aforementioned factors. Then, the most suitable structure was identified by analyzing the 
quality of fit between model predictions and data and by assessing the prediction accuracy of each one of 
the assumed model structures. A total of twenty-four variants of population-based model were considered 
based on combinations of different hypotheses regarding different triggering mechanisms for apoptosis, 
cross-talk between pathways and the presence of a limiting nutrient.  These variants are described later in 
the Chapter. 
For modeling purposes, cell subpopulations corresponding to the different mathematical states in the 
model are defined in terms of caspase activity as follows:   



































The modeling scheme is shown in Figure 5.1. According to this scheme, it is proposed that normal 
healthy cells (  ) undergo apoptosis via either of the two pathways as described above: the extrinsic 
pathway, forming caspase-8 active cells (  ) and the intrinsic pathway, forming caspase-9 active cells 
(  ). Eventually these two subpopulations progress either directly into caspase-3 active cells (  ), or 






) as shown in Figure 
5.1.  Finally the apoptotic cells (  ) undergo death thus converting into the final population (  ). These 
dead cells eventually disintegrate by lysis. A separate necrosis process acting in parallel to the apoptotic 
events was not included, since, as mentioned in Chapter 4, the examination of this cell culture by 
fluorescence microscopy and flow cytometry confirmed that there are very few necrotic cells (appearing 
red in fluorescence images) in the culture, and their numbers do not increase significantly with time. All 
living cells are capable of mAb production and so are considered viable (                   
   )   Rather than correlate the onset of apoptosis with the cessation of growth, the viable cell population 
was divided into two subpopulations: viable dividing/growing cells and viable non-dividing/non-growing 
or resting cells. The latter consume substrate for maintenance but not for growth. The fraction of viable 
cells in the growing state (   ), decreases as the culture grows.  It was initially hypothesized that growth 
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rate decrease and eventual growth arrest was due to a nutrient in either the medium or the serum that gets 
depleted. Accordingly, the fraction of growing cells was described by a modified form of the Tessier 
growth model (Moser, 1985) as follows, 
 
        
  
 
     
(5.1) 
where    is a constant and   represents a limiting nutrient. The dependence on the cell density (  ) 
accounts for a reduction in the specific growth rate at high cell density as a result of increased energy 
requirements for cell maintenance (Lee, 2002).  
Since it was found in earlier investigations that neither glucose nor glutamine are limiting in the culture 
conditions used in experiments, the identity of the assumed limiting nutrient(s) was not known. Goudar et 
al., (2005)  were also unable to find a growth rate limiting nutrient for their CHO cell line and employed a 
logistic model. So it was chosen to represent the residual fraction of a currently unknown limiting 
nutrient, denoted by  . Later in this chapter, a model comparison analysis is presented that aims to 
determine whether this limiting nutrient is contained in the medium or in serum. However, at later stages 
of this research it was found that growth arrest is mostly correlated to large changes in pH that are 
possibly due to accumulation of carbon dioxide in the medium. Since the mathematical model for the 
growth fraction as either a function of an unknown nutrient or an inhibitory compound is of similar 
mathematical structure, the model presented in this section follows the unknown nutrient assumption 
(Equation 5.1) to describe the change in the fraction of growing cells. However, later in a chapter 
(Chapter 8, Equation 8.2), the above was replaced by a dependency with respect to an inhibitor 
(accumulation of CO2) instead of the unknown nutrient.  
Following the definition of the fraction of growing cells, the growth rate of normal viable healthy cells is 
expressed as:  
               (5.2) 
where    is a constant parameter.   
Cells that are not yet caspase-3 active (  ,    and   ) are assumed to be growing as well.  Cells in these 
populations may not be actively undergoing apoptosis. Because dividing cells may continue at least one 
round of division while entering the apoptotic process (Meikrantz and Schlegel, 1995), growth of these 
sub-populations was allowed for in the model. Their growth rates are given by    
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                 (5.3) 
                 (5.4) 
                 (5.5) 
On the other hand, cells that have progressed further along the apoptotic pathway (  ) as indicated by 
activation of caspase-3 are considered to be growth-arrested.  




            (           )  (5.6) 
To account for cell-cell signaling activity, the rate of activation of the extrinsic pathway,     is taken to be 
dependent on the cell density (Hardy and Stark, 2002) as per the following nonlinear equation 
     (   (                       )
 )    (5.7) 
where     and α are constant parameters.  Since it is unclear whether these apoptosis-inducing signals are 
sent from all cells or just cells that have committed to apoptosis, several cases were considered. In one 
case, just cells with active caspase-3 were considered in Equation (5.7),  
     (     
 )   (5.8) 
In a second case, all cells were considered to be exchanging these signals 
     (     
 )   (5.9) 
For comparison purposes, a third case was considered in which signaling is not density-dependent as 
follows 
           (5.10) 
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The intrinsic pathway has been shown to be triggered via nutritional stress (Goswami et al., 1999; 
Sanfeliu and Stephanopoulos, 1999; Simpson et al., 1998b), and so this rate dependent on the limiting 
nutrient   can be described as 
       
 
     
    (5.11) 
where    and    are constants.  In contrast, and as mentioned in earlier chapters, some studies have shown 
that the accumulation of toxic metabolites may trigger this pathway.  Accordingly, an alternative 
formulation was considered in which the intrinsic pathway is triggered by the accumulation of ammonia: 
              (5.12) 
Experimental measurements of ammonia concentration were linearly interpolated for incorporation into 
model. Ammonia is inhibitory to mammalian cell growth at concentrations as low as 2.4–2.8 mM 
(Hansen and Emborg, 1994; Newland et al., 1994). Ammonia concentrations reached as high as 4 mM at 
the end of experiments; the concentration range was 1.5-2.0 mM when an increase in caspase-9 activity 
was first observed. The observations of lactate show that its levels follow a trend similar to ammonia, 
reinforcing the possibility that the increase in caspase-3 sub-population may be correlated to other toxic 
metabolites that may be involved in triggering the intrinsic pathway.  
The rates of internal apoptosis progression, as indicated in Figure 5.1, are presumed linear for simplicity, 
so that 
         (5.13) 
         (5.14) 
          (5.15) 
          (5.16) 
            (5.17) 
where    ,    ,    ,     and     are parameters.   
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The death rate of caspase-3 active cells (  )  is given as  
         (5.18) 
where      is a parameter. 
In the preliminary investigations, the dependence of this death rate on the ammonia concentration was 
explored and found based on the model identifiability analysis presented in the next section that any 





Figure 5.1: Balance between apoptotic subpopulations.  Healthy cells begin apoptosis by activation of the 
intrinsic pathway (C8) of the extrinsic pathway (C9).  The cells eventually trigger caspase-3, leading to 
late apoptosis and eventually death.  Cross-talk between the two pathways may lead to the presence of 
early apoptotic cells in which both initiator caspases are active. „ ‟ represents limiting substrate.  
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Finally, the lysis rate of dead cells is given as  
           (5.19) 
where        a parameter. 
As a final variant for model comparison, a model was considered in which the cross-talk between the two 
apoptotic pathways is negligible, so that the caspase-8 and -9 active population (  ) is absent. This is 
equivalent, according to Figure 5.1, to setting    and    to zero.  
The initial conditions for all the state variables were also estimated along with the model parameters. The 
initial condition for the limiting nutrient   was chosen to reflect hypotheses about the source of this 
nutrient.  In the first variant, the nutrient is presumed to be contained in the medium, and so the initial 
condition for   is fixed (at 1, units arbitrary).  In the second variant, the limiting nutrient is presumed to 
be contained in serum, and so depends on the initial serum concentration (at a level of 100 times the 
percentage serum level). 
To summarize, a total of twenty-four different model formulations were constructed involving the 
different hypotheses described above which in terms of the model variables are as follows: 
1. Limiting nutrient   present in medium or in serum (initial value of    is identical for all spinners or 
depends on initial serum concentration) 
2. Cross-talk (  ) absent or present 
3. Extrinsic pathway triggered by apoptotic signaling from all cells, caspase-3 active cells, or at a fixed  
rate (     (      
 )    or      (      
 )    or             ) 
4. Intrinsic pathway triggered by nutrient limitation or toxic stress by ammonia accumulation (    
   
 
     
    or               ) 
Each of the 24 model formulations was calibrated against the training data set, consisting of the 
experimental data in SP1 and SP4. The models were then compared based on their ability to predict the 
outcomes of the validation data set (the remaining experiments: SP2, SP3). Additional data set was also 
considered for validation to see the robustness of the developed model in terms of its prediction 
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capability. These additional dataset were obtained from experiments labeled SP5-8. The experimental 
conditions are given below (Table 5.1). (More details of these experiments are given in the next chapter). 
 
Table 5.1: Experimental conditions in additional validation data set 
experiment 




Glutamine (mM) Serum (%) 
SP5 0.18 1 0.5 
SP6 0.15 1 2 
SP7 0.64 4 0.5 
SP8 0.71 4 2 
 
 
5.1.2 Model fitting 
A system of differential equations was set up by applying material balances based on the model shown in 
Figure 5.1.  The model was simulated in MATLAB (Mathworks, USA). The integration of differential 
equations was performed using ode23s in MATLAB. Parameter fitting began with the use of a genetic 
algorithm to obtain approximate values of the optimal model parameters. In view of the nonlinearity of 
the resulting optimization problem, various initial guesses of parameters were provided for the 
minimization of the objective function. The sum of squared errors (SSE) was used as an objective 
function and was generated by comparing the model predictions to the data and weighting each squared 
residual by the size of the concentration (resulting in a relative measure of error): 
    ( )   ∑∑*
  ( )    ̂( )
  ( )
+
  
   
 
   
 (5.20) 
where   are the parameters involved in the model,   is the output that corresponds to the system 
measurements,      obtained at sampling time points at  ,      and   ̂ are the predicted outputs 
obtained by solving differential equations.  
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In each case, the final set of parameters obtained via the genetic algorithm was refined by subsequent 
application of a constrained nonlinear optimization function (MATLAB routine: fmincon). 
For minimizing the relative sum-of-squares errors (SSE) towards parameter estimation, the model state 










was compared to the sum of states    and    where the latter is defined as being 




was compared to the sum of states      and    where the latter is defined 
as being caspase-8 positive. In the case of   , due to experimental error there was generally a small 

















 although they should have been equal as 
explained in Chapter 4.  Hence, the state    was compared against the average of these two values.  
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 . The dead cell population    was compared to the dead cell count obtained from the trypan blue 
exclusion method.  
It was found necessary to add an additional weight to the second time point (at day 1.8) for the high-












 in this 
spinner were not well resolved by the measurements; an additional weighting (by a factor of 80) was 
required in order to force the early peaks observed in behavior.   
5.1.3 Model comparison and parameter identifiability analysis 
Because the model formulations involve different numbers of state variables and parameters, the fits to 
the experimental data were compared using the AICc, the small-sample-size corrected version of the 
Akaike information criterion.  This measure allows for comparison of model fits while taking into account 
the fact that some model formulations can take advantage of more degrees of freedom to fit the data, 
while others are constrained by additional comparisons to the data.  Presuming the errors are independent 
and normally distributed, the AICc is defined by      
          (
   
 
)   
   




where     is the minimized sum of squared errors,    is the sample size, and    is the number of model 
parameters. Also the AIC and the BIC (Bayesian information criterion) were applied and leading to 
similar results. 
Identifiability analysis was performed to assess confidence in the best-fit parameter values.  Identifiability 
was assessed by parametric sensitivity analysis, which indicates how variation in parameter values 
influences the behavior of the system. (Low sensitivity typically corresponds to low confidence in the 
calibrated parameter value). Overall sensitivity measures for each parameter were determined as in (Brun 
et al., 2002). The general procedure is as follows.  Consider the following system of differential equations  
 ̇   (     ) and     ( ) 
where   is the state vector,   is the parameter vector,   is time, and
 
  is the output that corresponds to the 
system measurements. The sensitivity of the    
 
parameter on the     output variable at sampling time   is 
given by the coefficient 
    (  )  
   
   
|
    
 (5.22) 
These can be organized into a sensitivity score matrix , as follows:  
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where the model has   outputs and     parameters, and measurements were taken at  time-points.  
In order to determine the identifiability of model parameters, the individual sensitivity scores in the 
sensitivity score matrix , were scaled as  
    
 (  )  
  
  
   (  )  
  
  
   
   
|
    
   (5.24) 
The orthogonalization method proposed by Yao et al., 2003 (as mentioned in Chapter 2, Literature 
review) was applied on this scaled sensitivity matrix to determine identifiable parameters. 
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After determining identifiability of parameters, confidence intervals for these parameters were obtained 
via the Fisher Information Matrix (FIM).  FIM is based the linearization of each of the responses in the 
neighborhood of the optimal parameter set   and signifies the amount of information contained in 
experimental measurements. The Fisher Information Matrix (FIM) was constructed from the original 
sensitivity score matrix given in Equation (5.23) by 
 




where    is the inverse of the covariance matrix of measured output error. The variance was estimated by 
using measurement replicates of the initial time-point to determine a coefficient of variation associated 
with the experimental assays (flow cytometry and trypan blue cell counting).  
The Cramer-Rao bound states that the inverse of the FIM represents the error covariance matrix of the 
minimum variance unbiased estimator (Kay, 1993), and thus a lower bound on the variance of the 
identifiable parameter can be obtained from the diagonal of the FIM as 
   (  )  (   
  )   (5.26) 
A 95% confidence interval for an identifiable parameter can then be obtained as 
          √ 
 (  ) (5.27) 
These confidence intervals reflect the degree to which each parameter value is constrained by the data.  
Parameters for which the sensitivity is low give rise to large confidence intervals, since their values are 
not well-constrained by the model outputs that correspond to data in this study.  





    √
 
 









5.2 Results and discussion 
Table 5.2 represents the minimal SSE scores for the 24 model variants and AICc measures, which 
incorporate both the training and prediction fits. As shown in the table, the best model variant (i.e. lowest 
AICc value, denoted in bold) has the limiting nutrient   present in the medium, incorporates cross-talk, 
has the rate of the extrinsic pathway expressed as a function of caspase-3 active cells, and has the rate of 
the intrinsic pathway expressed as a function of ammonia. The parameter values obtained after 
optimization for this best model variant are shown in Table 5.3, along with sensitivity measures, 
identifiability scores, and confidence intervals. Figure 5.2 shows the fit of the model to the experiments 
SP1 and SP4. Figure 5.3-5.5 shows the model prediction for experiments SP2-8. Overall, the model 
successfully predicts the dynamic behavior of the culture subpopulations for all initial cell densities. 
However, for the low cell density and high initial serum levels in SP6, the progression of apoptosis was 
not well captured. 
5.2.1 Model comparison results 
The five-state model out-performed the four-state model, even after taking into account, in the Akaike 
criterion calculation, the additional degree of freedom provided by the increased number of fitting 
parameters and the increased number of comparison used to fit the five-state model.  This suggests that 
cross-talk is occurring between the two apoptotic pathways in the current CHO cell culture. The best 
model performance occurred in the case where the signals that trigger the extrinsic pathway are generated 
by caspase-3 active cells (  ), suggesting that actively apoptotic cells are responsible for triggering 
apoptosis in the rest of the culture. This model variant was also compared with other variants based on 
AICc scores by computing the probability as per Equation (2.7), and found that this model variant was 
99.99% correct than the other model variants. The model sensitivity and identifiability analysis (discussed 
in the next section) shows that the parameter associated with cell density dependence has a strong effect 
on model behavior, indicating the prominent effect of cell density on apoptosis. The models performed 
significantly better when the intrinsic pathway was presumed dependent on the accumulation of ammonia.  
This suggests that build-up of toxic metabolites, rather than nutrient depletion, is responsible for 
triggering the intrinsic apoptotic pathway in this culture. 
The model comparison suggests that the liming nutrient is not present in serum.  Nevertheless, the current 
CHO cell line would not grow in the absence of serum. It was determined that the maximum specific 
growth rate was not serum-dependent for serum between 0.5% and 1.0%. The peak viable population 
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density was essentially the same for 0.5% to 1.0% serum, it increased by 40% with serum concentrations 
above 1%.  It was observed that the time where growth arrest occurred was not dependent on the serum 
levels (since the maximum cell concentration reached at the same time of day in both serum level cultures 
of 0.5% and 2%, Chapter 6, Figure 6.1) but the progression of apoptosis was. Together with the model 
comparison results, these observations suggest that when the serum is above 1% the growth-limiting 
nutrient is present in the medium, but some components of serum affect the dynamics of apoptosis. Later 
in this work it was found that spinner volume had an effect on the cell density peak. Based on this 
observation and after measuring low levels of pH during growth arrest it was later hypothesized that arrest 
may be related to inhibition by carbon dioxide. To account for these observations, the mathematical 
model was kept the same except that the limiting nutrient concentration ( ), used in the calculation of the 
fraction of growing cells (   ), as in Equation (5.1), was substituted by (1- ) where   is the inhibitor 
concentration. The results of the model using this correction are presented in Chapter 8. 
5.2.2 Model identifiability analysis 
Taking the best-performing model variant, an identifiability analysis via the orthogonalization method 
was applied to parameter sensitivities as described earlier.  The results of identifiability analysis are 
indicated in Table 5.3, along with the normalized 95% confidence intervals as determined via the FIM.  
The identifiability scores were calculated from the model itself, while the confidence intervals incorporate 
the experimental observations.  Consequently, the rankings of the parameters by these two measures are 
only approximately consistent. Not surprisingly, the growth parameters scored highest in terms of 
identifiability.  The least identifiable parameters are     ,    and   .  The first of these,     , is difficult to 
determine since lysed cells are not available for observation.  Parameter    represents the impact of 
nutrient   on the growth rate.  As described above, the growth profile shows a complex dependence on 
serum level, indicating that this aspect of the culture requires further investigation.  Finally,     describes 
triggering of the intrinsic pathway by the extrinsic pathway.  While the data seems unable to characterize 









Figure 5.2: Comparison of experimental observations with simulated profiles from the best-fit model 
variant. A-D: SP1 and E-H: SP4. The solid curves represent the simulated profiles and the data points 
represent the experimental observations. 
 
Figure 5.3: Comparison of experimental observations with simulated profiles from the best-fit model 
variant. A-D: SP2 and E-H: SP3. The solid curves represent the simulated profiles and the data points 




Figure 5.4: Comparison of experimental observations with simulated profiles from the best-fit model 
variant. A-D: SP5 and E-H: SP6. The solid curves represent the simulated profiles and the data points 
represent the experimental observations. 
 
 
Figure 5.5: Comparison of experimental observations with simulated profiles from the best-fit model 
variant. A-D: SP7 and E-H: SP8. The solid curves represent the simulated profiles and the data points 
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  1.27 14.34 3085.7 0.5206 
    0.69 day 
-1
 3.77 95.9 0.3667 




 5.40 68.2 0.1737 




 2.67 52.6 0.8689 
    2.66 day 
-1
 2.1 26.7 0.8046 






 3.29 12.4 0.3842 




 7.14 10.8 0.5717 
     0.15 day 
-1
 1.33 3.6 0.6168 
    5.1 day 
-1
 0.87 1.8 4.6677 
    4.06 day 
-1
 1.56 1.1 5.4017 
      0.1 day 
-1
 0.25 0.7 0.6770 
    0.47 mM 0.33 0.3 1.4185 
    0.003 day 
-1











Chapter 6  
Investigation of the effect of serum on growth 
Serum contains essential nutrients, growth factors, hormones and vitamins which are important for cell 
growth. As mentioned in earlier sections (Chapter 2) depletion of one or more components of serum could 
be a factor that leads to apoptosis. Hence, experiments were performed to assess the effect of different 
levels of serum in CHO cell culture, along with different initial cell densities. 
6.1 Materials and methods 
All experiments were performed with regular HyClone SFX-CHO medium. Batch cultures were set up in 
four 500mL spinner flasks, labeled SP5-8. The experiment in SP5 was designed to start with 0.25x10
6
 
cells/mL of cell density supplied with 0.5% of serum and 1mM glutamine, SP6 with 0.25x10
6
 cells/mL 
supplied with 2% of serum and 1mM glutamine; SP7 with 1x10
6
 cells/mL supplied with 0.5% of serum 
and 4mM glutamine; SP8 with 1x10
6
 cells/mL supplied with 2% of serum and 4mM glutamine. A 
calculated volume of seed culture according to the above mentioned initial cell densities, was centrifuged, 
supernatant was discarded and the settled cells were then suspended in fresh medium in respective spinner 
flasks and then supplemented with serum and glutamine. The measured initial cell density in the four 









 cells/mL respectively) due to experimental variability during the inoculation.   
6.2 Results and discussion 
Figure 6.1A shows the viable cell concentration profile in each case. As can be seen, for the higher initial 
cell density cultures, the cell culture quickly reached to a maximal density. For the same higher cell 
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density cultures but different serum levels (SP7 and SP8) the differences in terms of maximum cell 
concentration were not significant, thus indicating a negligible effect of serum concentration. For the 
lower serum level culture (SP7) the specific growth during the exponential phase, which was expected to 
be lower if there was a serum effect, turned out to be slightly higher compared to SP8, indicating no 
pronounced effect of serum (Table 6.1). In addition, the specific growth rate in SP8 was similar to the 
growth observed for SP4, described in Chapter 4, which used a higher serum level (4%) with similar 
initial cell density. In terms of viability, SP4, SP7 and SP8   exhibited similar values indicating no effect 
of serum.  
On the other hand, for the lower cell density cultures (SP5 and SP6), there was an effect of serum. The 
maximum viable cell concentration (shown in Table 6.1) reached in SP6 (2% serum,      = 1.24 x 10
6
 
cells/mL) was higher as compared to SP5 (0.5% serum,      = 0.87 x 10
6
 cells/mL). While comparing 
SP5 with SP1 (1% serum, as described in Chapter 4,      = 0.83 x 10
6
 cells/mL), no significant 
difference was found in the maximum viable cell concentration reached thus indicating small effect of 
serum when working with low serum concentrations of less than 1%. 
After comparing viability in the four different cultures (Figure 6.1B), it can be observed that viability is 
mostly correlated to initial cell density but is not significantly correlated to the initial levels of serum. 
Accordingly, the viability in SP5 is similar to SP6, and the viability in SP7 is similar SP8. 
Figure 6.2-6.3 shows flow cytometry forward scatter-side scatter (FSC-SSC) plots for the lower and 
higher initial serum level, SP5 and SP6 respectively. As the culture proceeds, the healthy culture 
disassociates into a less healthy culture containing more apoptotic cells as indicated by an increase in SSC 
of these cells. As can be seen in these graphs between days 1 and 3 most of the culture is still healthy as 
observed by a single cluster corresponding to lower values of SSC. Then, in the following days, an 
additional cluster appears with increased SSC values as compared to the SSC values of the healthy cells 
thus indicating increased number of apoptotic cells. Estimation of these apoptotic group of cells (in 
percentage), after gating, shows that there was not much difference in the overall degree of apoptosis for 










Table 6.1: Characteristic parameters 
 SP5 SP6 SP7 SP8 
 












Specific growth rate (day 
-1
) 0.49 0.68 0.30 0.23 




0.87 1.24 1.07 1.2 




1.29 0.94 1.03 0.78 
 










Figure 6.2: Bivariate distributions of cell samples for SSC vs. FSC in the low serum (SP5) and high 






Figure 6.3: Bivariate distributions of cell samples for SSC vs. FSC in the low serum (SP5) and high 
serum culture (SP6) 
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In terms of caspase-9, as shown in Figure 6.4, the higher initial cell density cultures (SP7 and SP8) 
exhibited higher activation compared to the lower cell density cultures (SP5 and SP6). On the other hand 
the activation of caspase-9 was not significantly different among different serum levels in these higher 
cell density cultures (difference was approximately 5%).  Considering caspase-3 activation (Figure 6.4), it 
was higher in the higher initial cell density cultures (SP7 and SP8) as compared to the lower cell density 
cultures (SP5 and SP6), but no significant difference was found among the higher initial cell density 
cultures in caspase-3 levels for different levels of serum. Comparing caspase-3 activation for different 
serum levels for the lower initial cell density cultures (SP5 and SP6), differences were observed 
indicating a slower activation of caspase-3 in SP6. Thus serum level affects caspase-3 activation 
dynamics, though the overall apoptosis level was found same by SSC-FSC plot in Figure 6.4A-B.  An 
earlier experiment with 1% serum and low initial cell density (SP1), described in Chapter 4, was also 
compared with SP6 that was initiated with the same low density value but with 2 % serum.  It was found 
from this comparison that the activation of caspase-9 and caspase-3 was similar for SP1 and SP6 thus 
corroborating that serum does not have a major effect on the dynamics of apoptosis for serum levels 














Figure 6.6 shows the time course of glucose and glutamine consumption and lactate and ammonia 
production for the four experiments described in this chapter. While, comparing lower cell density 
cultures, serum level did not seem to affect specific glucose consumption rate for low serum level cultures 
SP5 (Table 6.1) and SP1 (Table 4.2) and was higher compared to higher serum level culture (SP6) (Table 
6.1). Correspondingly, specific lactate production rates were similar for SP5 (Table 6.1) and SP1 (Table 
4.2) and higher compared to the higher serum level and low cell density culture (SP6). Similar 
observations were made for different serum levels and higher cell density cultures SP7, SP8 (Table 6.1) 
and SP4 (Table 4.2).  
Glutamine was depleted as the cell growth progressed. However, it was not completely depleted when the 
cell concentration reached its maximum for the higher cell density cultures with different serum levels 
(SP7 and SP8). In the lower initial cell density cultures (SP5 and SP6) with different serum levels, 
glutamine was almost depleted to zero because of the low initial glutamine levels used in these cultures 
(1mM). No difference was found in ammonia level for different levels of serum, but differences were 









The time evolution profile of mAb is shown in Figure 6.7. The concentration of mAb was not affected 
during the decline phase where mAb continued to be produced indicating that production is non-growth 
associated. A higher level of antibody was produced in the higher initial cell density culture.  
The average specific mAb productivity rates (  ) throughout the whole culture (calculated as shown in 
Appendix B) were determined for each culture. The plots of the time integral of viable cells i.e. ∫   
 
 
    
vs. mAb concentration from which the    was calculated as slope are shown in Figure 6.8. A statistical 
test (F-test) was performed on experimental measurements of mAb concentration (Figure 6.8) to check if 
there was any difference in the    among SP5-8. With this test performed, it was found that there was no 
difference in the    among SP5-8 (Appendix C). The test results could be improved by increasing the 
degrees of freedom, thus increasing the number of mAb measurements. However, from the slopes 
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obtained by regression on these measurements (Figure 6.7), different values of     for SP5-8 were 
obtained. Based on these slopes a  higher specific monoclonal antibody production rate was observed for 
the higher initial cell density cultures as compared to the lower initial cell density ones (Table 6.2). The 
antibody production rate was fairly constant throughout the culture regardless of cell density and serum 
level, although it was slightly higher during the decline phase corresponding to a slightly larger slope 
(Figure 6.8). It can be seen that for the lower initial cell density cultures the specific antibody production 
increased with serum level. Similar observation was found by (Dalili and Ollis, 1989) for hybridoma 
culture in T-flask level. However, in higher cell density cultures (SP7 and SP8), higher specific mAb 
productivity was found for SP7 where serum level was lower compared to SP8 (Table 6.2). Thus 
comparing specific mAb productivity for the similar initial cell density cultures but different serum levels, 
it can be observed that specific mAb productivity was higher for the culture exhibiting higher specific 
growth rate, regardless of serum level. Thus, according to the observation in Table 6.2, the mAb 
productivity appears to be positively correlated to specific growth rates but not to serum levels. Some 
previous investigations (Fox et al., 2004; Miller et al., 1987; Suzuki and Ollis, 1989) have reported 
increased specific antibody production rates with lower specific growth rates. Now this can be attributed 
to the type of cell line. Variability in the measurements of mAb concentration by ELISA can be observed. 
This variability can be due to inconsistency in standards, reagents or due to variability in handling, and 
analysis of data, and thus needs further improvement in the assay procedure. 
 
 
Table 6.2: Specific mAb productivity in different cultures obtained from the slope of plots in Figure 6.7 
 
 SP5 SP6 SP7 SP8 




0.18 0.15 0.64 0.71 
Specific growth rate (day 
-1
) 0.49 0.68 0.30 0.23 









Figure 6.7: mAb concentration profiles in different serum level cultures 
 
 




























Chapter 7  
Investigation of culture volume effect 
7.1 Introduction 
Chapter 6 described a series of experiments that were conducted with different serum levels and with 
different initial cell density cultures to elucidate whether growth arrest is caused by a limiting nutrient 
contained in serum. Since it was found from these experiments that growth arrest is not significantly 
affected by serum level, especially when this level is more than 1%, it was concluded that the limiting 
substrate is not in serum. Also, additional fed-batch experiments were conducted in a parallel study by 
Naderi, (2011) where medium was fed intermittently to the culture in order to test whether the limiting 
nutrient was contained in medium. Naderi found, even after feeding significant amounts of medium 
during the course of the experiments, no substantial improvements in terms of cell growth, maximum 
viable cell concentration, viability and mAb productivity. The possibility of toxicity effects due to lactate 
or ammonia accumulation was also ruled out as a cause for growth arrest since their concentrations were 
well below inhibitory levels at the moment of growth stoppage. Inhibitory levels were only reached 
towards the end of the experiments (~ 12-15 days). 
Consequently, it was hypothesized that other factors like oxygen limitation or accumulation of toxic 
metabolite like CO2 could be the cause of growth arrest and triggering of apoptosis during the early stages 
of the cultures (~3-4 days). It was hypothesized that CO2 accumulation may occur due to slower release 
of CO2 from the spinner into the atmosphere due to low surface area to  culture volume ratio. To test this 
hypothesis experiments were conducted in spinners of different volumes and differences in growth and 
mAb productivity were investigated. 
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7.2 Materials and methods 
Experimental design 
Experiment was carried out with regular SFX-CHO medium supplemented with 1mM glutamine and 1% 
serum in 500 mL capacity spinner flasks. Four batch cultures were set up labeled SP9-12 with different 
working volumes: 150 mL, 250 mL, 375 mL and 500 mL respectively. All the spinners were inoculated 
with a common seed culture. The spinners were seeded without a previous centrifugation step as done in 
the earlier experiments described in Chapter 4 and 6. The same initial cell density of 0.25 x 10
6 
cells/mL 
was used in all the different volume cultures. 
Regular sampling was performed to monitor viable and dead cell concentration, pH, dissolved oxygen, 
glucose, lactate and ammonia. 
7.3 Results and discussion 
The progression of viable cell concentration with time in the different volumes is shown in Figure 7.1. As 
can be seen, the maximum viable cell concentration reached during the experiments was highest in the 
lower volume culture as compared to the other cultures. This figure clearly indicates that there is an 
inverse correlation between the cell density maxima and the volume of the culture.  The viable cell 
concentration profile in 125 mL culture is somewhat similar to the profile obtained in the 250 mL culture. 
It appears that this similarity is due to the fact that in the 125 mL culture there was not enough room to 
fully accommodate the agitator within the broth and consequently, it remained partially outside the broth. 
This situation became more pronounced along the culture due to the loss of liquid following frequent 
sampling for analysis purposes. For this reason, the data collected for the 125 mL culture was not used in 
the following comparisons. 
The maximum cell concentration reached in these experiments was approximately 1.6 x 10
6
 cells/mL in 
the 250 mL, which was the lowest volume left after discarding the 125 mL experimental data for the 
reasons explained above. The dead cell concentration progression was similar in all volume cultures 
(within a 5% difference). Regarding the specific growth rates, calculated as the average specific growth 
rate during the exponential phase, the highest value was obtained in the lower volume experiment (250 
mL, SP10); it was found to be 0.52 day
-1
 (Table 7.1), while the growth rates in the higher volume 








In order to assess the causes for growth arrest, pH was measured along the experiment. As can be seen 
from the pH profile (Figure 7.2), the drop in pH in the 500 mL culture was significantly more pronounced 
than in the 250 mL and 325 mL cultures. In the 500 mL experiment the pH dropped to a range of ~6.3-6.4 
which has been reported to be inhibitory to cell growth (Link et al., 2004; Yoon et al., 2005). The steepest 
drop in pH occurred around the time when the cell concentrations reached their maximal values, thus 
suggesting an inhibitory effect of pH on cell growth, possibly due to CO2 accumulation. Though the 
levels of CO2 in the culture were not measured, it can be suggested that the slow removal of CO2 due to 
mass transfer limitations and low driving force between the broth and the environment could lead to 
accumulation of CO2 to inhibitory levels (Pattison et al., 2000). Thus, the lower cell density in the 500 mL 
culture, compared to the density observed in the 250 mL spinner, can be attributed to poorer CO2 removal 
in the culture due to increased volume to mass transfer area ratio. 
As stated above the possibility that either ammonia or lactate were inhibitory was also ruled out in the 
current experiments as the ammonia and lactate levels, shown in Figure 7.2, were similar in all the 
different volume cultures and was below the inhibitory levels reported in the literature (Figure 7.2). To 
confirm that growth arrest was not related to oxygen depletion, dissolved oxygen was measured during 
the experiments. The dissolved oxygen in all the cultures ranged between 40-80% (Figure 7.3), which is 
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sufficient for the cell growth and not in the limiting range that can lead to conditions of hypoxia (Ozturk 
and Palsson, 1990b; Shu and Liao, 2002; Trummer et al., 2006). 
Figure 7.4A shows the time evolution of mAb concentration in each different volume. For the 250 mL 
culture, the final mAb concentration obtained was higher (46 µg/mL) than the higher volume cultures 
(500 mL and 375 mL), although there was no pronounced difference found in the specific mAb 
productivity between the different volumes (Table 7.1). The specific mAb productivity was determined 
from the slope of the mAb concentration and time integral of viable cells (Figure 7.4B)  according to the 







Table 7.1: Specific growth rates in different volume culture 
 SP10 SP11 SP12 
Culture volume (mL) 250 375 500 
Specific growth rate (day 
-1
) 0.52 0.37 0.38 




1.75 1.28 1.10 









Figure 7.2: pH, glucose, ammonia and lactate concentration profile in different volume culture 
 
 




Figure 7.4:  (A) Time course of mAb concentration (B) mAb concentration as a function of time integral 















Chapter 8  
Integration of apoptosis and metabolic flux 
models to predict mAb production 
 
8.1 Introduction 
A key objective of the current research was to develop a comprehensive model of mAb production that 
will be used ultimately for optimizing culture conditions to maximize productivity. With this objective in 
mind it was necessary to integrate the population-based model of apoptotic progression (Chapter 5) with a 
model of extracellular metabolite concentration, since it will be the latter that can be manipulated for the 
purpose of optimization.  This integrated model can provide a better understanding of cell behavior and 
help in devising strategies for delaying its onset. Since it was found in earlier phases of this work that 
mAb is non-growth associated, a model of both normal healthy and apoptotic cells is required to predict 
the mAb profile. Then, mAb productivity of the individual subpopulations in the apoptosis model was 
described separately. This chapter describes the integration of the metabolic flux model of extracellular 
metabolites with the population based model of apoptosis previously described in Chapter 5. Since it was 
found in Chapter 7, by experimenting with different culture volumes, that growth arrest is correlated to 
the accumulation of an inhibitory compound, the apoptosis model of Chapter 5 was slightly changed to 




8.2 Materials and methods 
The models to be integrated are described as follows 
8.2.1 Metabolic flux model 
During the early stage of culture, when cells are in an exponential growth phase, the majority of the cell 
population is composed of normal growing/dividing cells, although there are always a low number of 
apoptotic cells. At approximately day 3-4 growth arrest occurs resulting in normal growing cells shifting 
to a non-growing state (possibly due to G0 cell cycle phase arrest or G1 phase arrest at the G1/S 
checkpoint). On the other hand the sub-population of apoptotic cells continues to increase and reaches a 
maximum 3-4 days after the total cell density peaks, i.e.  6-7 days after the start of the culture. At the 
same time the apoptotic cell pool is slowly replaced by dead cells.   
Recalling apoptosis population balance model developed in Chapter 5, the viable subpopulation was 
presented as  
                       
The subpopulation    denotes caspase-3 active cells corresponding the late apoptosis phase, where cells 
exhibit blebbing onto the membrane surface and then disintegrate into apoptotic bodies. Due to the 
significant differences between these cells and the rest of the population,     cells were considered as the 
true apoptotic cell subpopulation.  
The metabolic flux model presented below (Figure 8.1) was developed by another PhD candidate (Naderi, 
2011). The method is based on conducting a metabolic flux balance in which, following the calculation of 
fluxes, the reactions corresponding to the insignificant fluxes are eliminated from the network to simplify 
the model. Then, after assuming that there is no accumulation of intermediate metabolites, these 
intermediates are eliminated by combining reactions and obtaining a set of macro-reactions that relate 
nutrients to products as follows  
          (8.1) 
           (8.2) 
                  (8.3) 
               (8.4) 
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                (8.5) 
                (8.6) 
                     (8.7) 
                (8.8) 
 
where      : Glucose,      : Lactate,     : Glutamate,     : Ammonia,     : Asparagine,     : 
Aspartate,     : Alanine 
The reaction rates associated to these macro-reactions are formulated using Michaelis-Menten kinetics as 
per the following expression:  
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(8.9) 
where   ( ) is the reaction rate for  
    reaction;    and    are the corresponding nutrient/metabolite 
concentration and half-saturation constant, respectively,     and     are the viable growing and viable 
non-growing cell concentrations. As shown, the model provides two distinct terms for each metabolic 
rate: a “growth associated” term corresponding to growing cells (  ) and a “non-growth associated” or 
maintenance term attributed to the population of non-growing cells (   ), which contains normal resting 
and apoptotic cells (  ). To model the metabolite dynamics, it was assumed that growing cells, (  ) and 
non-growing cells (   ), both normal and apoptotic, may metabolize nutrients at different rates. Thus     
and      are the maximum rate at which the reaction can proceed. 
Because of the higher substrate concentration in the exponential phase during which the majority of cells 
are growing, the nonlinear term associated to growth becomes close to unity, so Equation (8.9) was 
simplified to: 
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As defined the Chapter 5, the term      represents the fraction of dividing cells and defines the population 
of growing cells (  ). Thus the term    was represented as  
        (     ) (8.11) 
And the population of non-growing cells (   ) was represented as 
           (8.12) 
104 
 
The metabolic model to be coupled with the apoptosis population balance model described in Chapter 5 is 
shown as follows 
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8.2.2 Apoptosis model of Chapter 5 modified to account for inhibitor 
accumulation 
Based on the findings of Chapter 7 and as explained in the introduction of this chapter, growth arrest was 
found to be mostly correlated to inhibition possibly caused by carbon dioxide accumulation.  Although 
carbon dioxide concentrations could not be measured, the model presented in Chapter 5 was modified to 
account for this inhibitory effect. It should be recalled that the model in Chapter 5 related the fraction of 
growing cells to the depletion of an unknown nutrient  . Since the experimental investigations with 
different serum levels and media addition did not confirm such depletion, an inhibition by a volume-
dependent compound with concentration ( ) was assumed instead. As illustrated previously in Chapter 7, 
this inhibitory agent could be attributed to the buildup of CO2 during culture operation. It was thought that 
in order to improve productivity, this inhibitory effect could possibly be reduced by operating the culture 
in perfusion mode after the maximum cell concentration is reached, so that the CO2 concentration is 
brought back below its inhibitory level following perfusion. Attempts were made toward this direction 
(Naderi, 2011). Accordingly, partial successive medium-replacement was performed after the maximum 
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cell concentration was reached, and fresh medium supplemented with serum and glutamine was fed to 
replace the volume that was removed. It was observed that the cell growth was renewed but it could not 
attain the same levels as before. Moreover, after each medium-replacement, the cell concentration 
maximum reached a lower level than the previous cell concentration maximum, and the maxima 
consistently decreased in all successive medium-replacement. This consistent decline in cell maxima 
observed by Naderi, (2011) seems to indicate an irreversible damage to the cells each time the cells are 
exposed to inhibitory effects of either pH or carbon dioxide. To model this inhibitory and irreversible 
effect on cell growth, the fraction of growing cells     as represented in Equation  (5.1)  was modified by 
replacing the effect of unknown limiting nutrient ( ) , as follows 
 
       
   
     ∫    
 
 
   (8.21) 
where   represents the inhibition factor concentration in the culture while    and    are the inhibitory and 
accumulation constants respectively. The integration term accounts for the accumulation effect of CO2 
causing irreversible cell damage and resulting in progressive reduction in the ability to grow following 
exposures to inhibitory levels of  . The net rate of production of     was expressed as follows 
   
  
       (     )     (     )(     )           (    )   (8.22) 
where    ,     and     are the specific CO2 production rate by three subpopulations viz., normal growing, 
normal non-growing and apoptotic cells. The last term refers to the release of dissolved CO2 of the culture 
to the environment.    would correspond to the CO2 concentration in equilibrium with gas phase in 
headspace and     is a mass transfer coefficient that depends on the surface area of the culture with the 
environment and agitation rate. 
The dependence of ammonia on specific death rate (  ) of caspase-3 active cells which not included in 
the earlier apoptosis model in Chapter 5, was included in the integrated model as follows 
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A mAb productivity model was also formulated. Initially it was assumed, for simplicity, that the dynamic 
model for mAb could be described by lumping the production rates of growing, resting and apoptotic cell 
populations, given by 
   
  
      (8.24) 
where P refers to mAb concentration and    is the specific production rate for both growing and non-
growing cells. This relation was based on the assumption that the productivity of normal and apoptotic 
cells is equal. However, in later stages of the research, this assumption was further tested by assuming 
different productivity rates of normal and apoptotic cells. 
A combined model coupling the extracellular metabolites balances (Equations 8.13-8.20), the apoptosis 
model described in Chapter 5 with the modification for     (Equation 8.21) and the mAb productivity 
model (Equation 8.24) with incorporation of balance equation of inhibitory component (Equation 8.22) 
was formulated and calibrated with experiments. A schematic of the integrated model is shown in Figure 
8.2.  Initial guesses for parameter estimation were obtained by a genetic algorithm. In view of the 
nonlinearity of the resulting optimization problem, various initial guesses of parameters were provided for 
the minimization of the objective function (SSE). In each case, the final set of parameters obtained via the 
genetic algorithm was refined by subsequent application of a constrained nonlinear optimization function 
(MATLAB routine: fmincon). The integral in Equation (8.21) was evaluated by a trapezoidal rule while 
simulating the model. The model was implemented in MATLAB (Mathworks, USA) and the differential 
equations were integrated with the function ode23s. The parameters of the model were calculated with the 
fmincon optimization algorithm in MATLAB by minimizing the sum of square errors between model 
predictions and experimental data. The experiments described in Chapter 4, SP1 (lowest initial cell 
density culture) and SP4 (highest initial cell density culture), were used for fitting these parameters and 
the model was then validated with data from SP2-3 and SP5-8. The parameters associated with this 






Figure 8.2: Combined model of apoptosis, metabolite and monoclonal antibody production for current 





8.3 Results and discussion 
The combined model, as shown in the Figure 8.2, involves interactions by which the two models, the 
apoptosis and metabolic flux model, were connected. These connections were established with    ,      , 
    and    . The connections with    , and      describes the metabolic flux model (Equations 8.13 - 
8.20). The connection with     comes from the Equation (8.11) and the connection with     comes 
from Equation (5.12). The effect of an unknown inhibitor as described by the balance Equation (8.22) is 
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incorporated in the      term (Equation 8.21) which, in further, is incorporated in the apoptosis model in 
the growth rates of subpopulations    ,   ,    and    (Equations 5.2 - 5.5). 
The fitting of the model with data from SP1 and SP4 is shown in Figure 8.3 for the different cell 
subpopulations. Figure 8.4 and Figure 8.5 show fitting of extracellular metabolites in SP1 and SP4 
respectively. Model predictions for SP2-3 and SP5-8 are shown in Figure 8.6-14. 
It was found that the comprehensive model is able to reasonably predict the concentrations of various 
subpopulations, nutrients, metabolites and mAb. 
Model identifiability analysis was also performed on this integrated model to assess the confidence on 
parameter estimates. The steps described in Chapter 5 were followed. The ranking of identifiable 
parameters was pretty consistent with that found with the single apoptosis model developed in isolation as 
presented in Chapter 5. It was found in the integrated model that the parameter    associated with 
integration term to be highly identifiable followed by the parameter   associated with cell density 
dependence. The parameters   ,   ,    and     were also found highly identifiable, while the least 
identifiable parameters were    ,    ,   ,   ,    ,   ,    . The identifiability ranking of parameters 









Figure 8.3: Comparison of experimental observations with simulated profiles of cell subpopulations. A-
D: SP1 and E-H: SP4. The solid curves represent the simulated profiles and the data points represent the 
experimental observations. 
 
Figure 8.4: Comparison of experimental observations with simulated profiles of metabolites in SP1. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 




Figure 8.5: Comparison of experimental observations with simulated profiles of metabolites in SP4. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 
„ ‟ represents the inhibitory factor. 
 
 
Figure 8.6: Comparison of experimental observations with simulated profiles of cell subpopulations. A-





Figure 8.7: Comparison of experimental observations with simulated profiles of metabolites in SP2. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 
„ ‟ represents the inhibitory factor. 
 
Figure 8.8: Comparison of experimental observations with simulated profiles of metabolites in SP3. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 




Figure 8.9: Comparison of experimental observations with simulated profiles of cell subpopulations. A-




Figure 8.10: Comparison of experimental observations with simulated profiles of metabolites in SP5. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 




Figure 8.11: Comparison of experimental observations with simulated profiles of metabolites in SP6. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 
„ ‟ represents the inhibitory factor. 
 
Figure 8.12: Comparison of experimental observations with simulated profiles of cell subpopulations. A-





Figure 8.13: Comparison of experimental observations with simulated profiles of metabolites in SP7. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 
„ ‟ represents the inhibitory factor. 
 
Figure 8.14: Comparison of experimental observations with simulated profiles of metabolites in SP8. The 
solid curves represent the simulated profiles and the data points represent the experimental observations. 




Chapter 9  
Investigation of cell growth and mAb 
productivity following medium-replacement 
 
9.1 Introduction 
The experiments described in this chapter were conducted to investigate whether medium-replacement of 
the cell culture can help to mitigate the inhibitory behavior observed during growth arrest. To this end 
Naderi, (2011) performed successive partial successive medium-replacements of 50 mL every time after 
cells reached a new maximum concentration in order to reduce the effect of CO2 on growth.  Naderi 
found that after each partial medium-replacement the cells concentration maximum was lower than the 
previous peak. This motivated to experiment with full medium-replacement to assess whether cell growth 
can be renewed thus resulting in higher cell density and mAb productivity as compared to a normal batch 
operation. This was also an attempt to test whether the trend toward reduced cell growth and apoptosis 
could be reversed before pH values dropped to non-optimal levels. To test whether pH effects could be 
mitigated, an additional experiment was performed in which pH was maintained at a value suitable for 
growth by addition of a base. The integrated model developed (as described in Chapter 8) which 
incorporates inhibitory effect „ ‟ was also used to predict the cell behavior in medium-replacement 
operation. The predictions were also compared with that obtained by integrated model which incorporated 
the effect of unknown nutrient „ ‟ as described in Chapter 5. 
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9.2 Materials and methods 
All the cultures were grown in 500 mL spinner flask suspended in SFX-CHO medium supplemented with 
1% serum and 1mM glutamine. A set of four different cultures labeled SP13-16 were prepared. The 
cultures were prepared without centrifugation (unlike the previous experiments described in Chapter 4 
and 6 where centrifugation was done to achieve higher initial densities).  All the cultures were seeded 
with the same initial cell density of 0.25 x 10
6 
cells/mL. 
The medium-replacement step was performed by centrifuging the cells, removing the spent medium and 
suspending the centrifuged cells in fresh SFX-CHO medium. Serum and glutamine in proportions to the 
cell density measured after the replacement step was added. This was done to avoid nutrient depletion for 
the increasing cell densities resulting after each successive medium-replacement step. 
Culture SP13 was used as a control without any medium-replacement or pH adjustment. 
The cultures labeled as SP14 and SP5 were used for medium-replacement. Full medium-replacement was 
performed in these cultures just after the density reached a maximum value. However, since it was 
impossible to know a priori the exact time where the maximum cell density occurred, it was decided to 
perfuse the culture after the cells dropped by an amount corresponding to approximately 25% of the cell 
maximum in the post-exponential phase. The culture in SP4 underwent a single full medium-replacement 
while that in SP15 was used to test two full medium-replacements where each one of these were 
performed after the cell density dropped by 25% with respect to the maximum density achieved before 
medium-replacement step. The first medium-replacement was performed on day ~8 (day 7.9) in both 
SP14 and SP15 and the second medium-replacement was performed in SP15 on day ~14.   
The culture in the spinner labeled as SP16 was used for controlling the pH by base addition. 1N NaOH 
was used for this purpose. The pH was assessed, and whenever pH dropped below 6.9, base was added to 
bring it back to 7.1-7.15. Since it was not possible to monitor the pH online as the spinner was maintained 
inside the incubator, the amount of base to be added was determined by generating a titration curve. A 
previously made culture in the decline phase was used to generate this titration curve (The titration curve 
is shown in Appendix F). 
Regular sampling was performed to monitor viable and dead cell concentration, pH, dissolved oxygen, 
glucose, lactate and ammonia. In addition apoptosis was assessed by measuring active caspase-3, capsase-
8 and caspase-9 as per the methods described in Chapter 4. 
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9.3 Results and discussion 
9.3.1 Culture growth 
Viable and dead cell concentration profiles for the four cultures are shown in Figure 9.1 and Figure 9.2. It 
can be seen that in SP13, SP14 and SP15, the maximum cell concentration was reached at approximately 
day 4 and during this period the pH values dropped from 7.1 to ~6.4 (Figure 9.3). After the first full 
medium-replacement was implemented in SP14 and SP15 the cells exhibited additional growth but they 
could not attain the same maximum observed before medium-replacement. Similarly, after the second full 
medium-replacement was applied in SP15 some additional growth was observed in this spinner but the 













The culture in SP16, where pH was controlled by base addition, exhibited significantly different behavior 
than the other three cultures.  The specific growth rate in SP16 was significantly higher at approximately 
0.55 per day (Table 9.1) and the maximal cell density was reached much faster in about three days and 
then the cells died rapidly (Figure 9.1 and Figure 9.2) due to glucose depletion to zero levels (Figure 9.4) 
(Table 9.2). The specific glucose consumption rate in SP16 was almost 3 fold higher than in the other 
three cultures. 
Thus, maintaining the pH in the range of 7.1-7.15 helped in increasing specific growth rate but due to 
rapid depletion of glucose likely associated to higher metabolic activity, the culture could not attain the 
higher maximum cell concentration. It can be hypothesized that if initial glucose concentration had been 
higher, or if  additional glucose had been added after depletion, the culture could have reached a higher 
maximum cell concentration than the other three cultures. Controlling glucose addition to avoid depletion 
while pH is controlled is left for future studies. 
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It was also observed that the higher glucose consumption rate in SP16 was accompanied by higher level 
of lactate production than in the other cultures (Figure 9.5) with an average specific production rate of  
13.8  mM /10
6 
cell/mL day (Table 9.2). This higher metabolic activity in terms of glucose consumption 
and lactate production can be possibly attributed to higher glycolytic activity of enzymes. It has been 
found that pH has a profound effect on metabolism. It has been observed that the decrease in pH led to 
decrease in both the glucose consumption rate and lactate production rate resulting in reduced metabolic 
activity with various cell lines (Birch and Edwards, 1980; Miller et al., 1988; Ozturk and Palsson, 1991; 
Reddy and Miller, 1994; Sauer et al., 2000). Thus, maintaining the pH in a range of 7.0-7.2 seems to 







Table 9.1: Specific growth rate in cultures 
 SP13 SP14 SP15 SP16 
Specific growth rate (day 
-1
) 

































Figure 9.3: pH profile
 




Figure 9.5: Lactate production 
 
 
Table 9.2: Specific glucose consumption (    ) and lactate production rate (    ) 
 SP13 SP14 SP15 SP16 







































(calculated during first exponential phase) 
4.8 4.4 1.9 13.8 
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Alternatively it can also be suggested that the optimal pH alters the cell membrane potential affecting 
glucose transport rate, thus increasing metabolic activity (Wilhelm et al., 1971). On the other hand the 
cultures SP3, SP14 and SP15 grew with approximately similar specific growth rates of 0.46, 0.45 and 
0.41 per day (Table 9.1) and reached maximum cell concentrations of 1.15 x 10
6
, 1.2 x 10
6
 cells/mL and 
1.14 x 10
6
 cells/mL respectively. After the first medium-replacement, the specific growth rate increased 
almost two fold in SP4 and SP5 (Table 9.1). This again can be attributed to the optimal pH values attained 
after replenishing the spinner with fresh medium and with higher levels of glucose, glutamine and serum 
combined with the higher cell density in the spinner after medium-replacement as compared to the initial 
density at the start of the culture. A slightly higher specific glucose consumption rate was observed (Table 
9.2) than before medium-replacement, resulting in rapid depletion of glucose (Figure 9.4). This higher 
glucose consumption rate was accompanied by a large increase in lactate production levels, both of which 
can be attributed to the high cell. The ammonia production rate was also increased after medium- 
replacement (Figure 9.6). 
In the second medium-replacement implemented in SP15, the specific growth rate decreased considerably 
as compared to the growth observed after the first medium-replacement, resulting in a slight decrease in 
glucose consumption rate to 1.02 mM/10
6 
cells/mL day. The ammonia production rate also decreased 
after the second medium-replacement. The decrease in specific growth rate can be attributed to 
accumulative damage from pH or CO2 mentioned in Chapter 8.  In principle, cells can remain indefinitely 
in a non-growing non-apoptotic state or switch into apoptosis at any time. Cells usually staying at the 
G1/S checkpoint (R1, as described in Chapter 2 in Figure 2.1) can eventually undergo cellular senescence 
and apoptosis. Once the cells reach critical levels of inhibitory stress due to for example pH drop or acidic 
environment, the cells cannot revert to normal growing conditions and they remain in this non-
proliferative state for an indefinite amount of time or switch to apoptosis.  
In eukaryotic cells, environmental stress related growth arrest has been found in previous studies to be 
related to depression of pH (Cipollaro et al., 1986) and/or elevated  temperature  (Rincheval et al., 2002) 









9.3.2  Apoptosis progression 
Significant differences were observed in terms of capsase-8, caspase-9 and caspase-3 levels. Figure 9.7 
shows the progression of these caspases in each one of the four cultures, while Figure 9.8 and Figure 9.9 
compare the levels of each one of the caspases among the different cultures. It can be seen from Figure 
9.7 that in all the cultures the proportion of caspase-9 cells were higher compared to caspase-8 and 
caspase-3 active cells. Apoptosis was minimal, as seen by minimal caspase active population, 
approximately during the first three days in all the cultures. However, due to progressive cell density 
increase, the pH in all cell cultures (SP13, SP14, SP15) except the one where pH was controlled (SP16) 
dropped to a value of 6.6 at approximately the time where the cell concentration reached a maximum 
value, After this time, cell viability started decreasing and the caspase-active populations started 




Figure 9.7: Comparison of percent caspase-8, caspases-9 and caspase-3 cells evolution in the culture 
 
 








It can be observed in SP13, the culture without medium-replacement or pH control, that the instantaneous 
caspase-9 active cell population levels after SP14 and SP15 underwent their first medium-replacement 
events were higher, possibly due to higher pH-related stress in SP13 as compared to SP14 and SP15. 
Thus, it appears that prolonged exposure of cells to this higher acidic environment also affected the 
evolution of apoptosis in SP13, leading to around 80% apoptotic population towards the end of this 
culture. 
In SP16, the culture where pH was controlled by base addition, after day 3, the apoptotic cell population 
rapidly increased possibly due to near depletion glucose or excessive osmolality. Osmolality could not be 
measured directly. Instead, conductivity was recorded as an indirect measure of osmolality. No significant 
differences were found in conductivity levels in all the cultures; it remained at an average level of 13.3 
mS/cm with a standard deviation of 0.3 units. Thus, the observed high rise in the apoptotic cell population 
in SP16 can primarily be attributed to glucose depletion to zero levels occurring at around day 3. As 
126 
 
mentioned in Chapter 2, nutrient depletion can lead to apoptosis due to DNA damage (Burhans et al., 
2007) via the intrinsic pathway of apoptosis leading to caspase-9 activation. This is corroborated by the 
fact that the levels of caspase-9 active cells were higher in SP16 as compared to caspase-8 or caspase-3 
active cell populations and rapidly reached to around 75% towards the end of culture. Also, the caspase-9 
active cell population was higher in this culture compared to the corresponding populations in SP13, 
SP14 and SP15, due to the rapid depletion of glucose. It was also observed in SP16 that the caspase-8 and 
caspase-3 active cell populations were higher compared to those in SP13, SP14 and SP15 (Figure 9.8). 
This may be explained by the fact that there is feedback between the intrinsic and extrinsic apoptotic 
pathways thus high activation of caspase-9 may also cause activation of caspase-8 and vice versa (see 
model schematic in Figure 5.1, Chapter 5). 
In SP14 and SP15, after medium-replacement, there was a slight decrease in proportion of caspase active 
cell populations due to loss of cells in centrifugation and then due to dilution into the fresh medium. It can 
be seen in Figures 9.8 and 9.9 that the medium-replacement did not really help in reviving the cells or in 
reducing the degree of apoptosis as compared to that in SP13, the negative control. The apoptosis 
progression in terms of the caspase-active cell populations was similar in all these cultures even after the 
medium-replacement event. This suggests that cell growth arrest occurring after a drop in pH before 
medium-replacement was not reversible. At the same time, the remaining normal non-apoptotic 
population attained rapid growth after medium-replacement following the replenishment of medium but 
due to the initial high density relative to the density at the beginning of the experiment, the build-up of 
CO2 and drop in pH occurred faster which led them to become apoptotic earlier as compared to the period 
of growth before medium-replacement. 
9.3.3  Monoclonal antibody production 
The operation of the culture with successive medium-replacements had a profound effect on mAb 
production. Figure 9.10 shows differences in mAb production for these different cultures. In general, it 
can be seen that the rate of mAb production during the exponential and during the post-exponential phase 
are different as observed by the change in slopes after the end of the exponential phase. The pH-
controlled culture in SP16 remained in exponential phase for the first three days and then entered a 
decline phase where mAb production suddenly increased, possibly due to higher production rates 
contributed by growth arrested and apoptotic cells. Similar observation was reported in other cultures as 
well (SP13, SP14 and SP15).  
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In SP13, the final mAb concentration obtained at the end of the operation (around 21 days) was 
approximately 90 µg/mL. When considering mAb production just before each medium-replacement event  
and after the end of culture, a total mAb yield of approximately 100 µg/mL in single medium-replacement 
culture (SP14) and 135 µg/mL in double medium-replacement (SP15) was attained. Thus operating the 
culture in medium-replacement mode and optimizing the time of replacement can enable significant 
improvements in mAb productivity. As can be seen in SP16, where the exponential phase lasted for 
approximately three days (Figure 9.1), there was a sudden increase in the mAb profile when the culture 
entered into the decline phase after three days of exponential phase. Similar observation can be made with 
regards to the culture in SP13, SP14 and SP15 where the exponential phase lasted up to four days (Figure 
9.1). However the increase in  mAb levels in the decline phase looks higher in SP16 than other cultures, 
indicating higher specific mAb productivity in SP16 compared to SP13, SP14 and SP15. The specific 
mAb productivity (calculated over the whole corresponding culture time) for SP13 (negative control) and 
SP16 (culture with pH control) is shown in Table 9.3. As can be seen from this table, the specific mAb 
productivity obtained for SP16 was 6.9 (mM/10
6 
cells/mL day) while that for SP13 was 4.75 (mM/10
6 
cells/mL day). The specific mAb productivity for SP14 and SP15 could not be calculated at this point 
because of insufficient data. As mentioned earlier in Chapter 5, variability in mAb assay by ELISA can be 
observed (particularly in SP3, Figure 9.10). And thus needs further improvement in the assay procedure. 
 
 
Figure 9.10: Effect of different culture operation modes on mAb production 
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Table 9.3: Specific mAb productivity in SP13 and SP16 
 SP13 SP16 
 









Finally, the predictive capabilities of the model that is described in Chapter 8 were tested by comparing 
model predictions and data for the experiments SP14 and SP15 described in this chapter. Initially the 
model was simulated with the same parameters‟ values obtained in the Chapter 8. However, using these 
parameters, the model underpredicted the normal healthy cell population data. A possible explanation for 
this lack of fit is that in SP13-16 the cells were grown without previous centrifugation of the seed culture 
possibly resulting in higher cell growth than those cultures used for fitting which underwent such 
centrifugation step. For this reason the parameter    was varied for prediction of the data obtained in 
SP14-15. Also since there was change in specific growth rate in these cultures, there was also an observed 
change in mAb productivity. Accordingly, the specific mAb productivity    was also varied. Finally, to 
test the hypothesis of whether the different cell subpopulations (i.e. normal growing, normal non-growing 
and apoptotic) have different associated mAb production rate, different parameters were used for 
productivity as per the following equation: 
  
  
    (           )        
The sum             corresponds to normal growing and nongrowing cells as per the notation used 
in Chapter 5 and Chapter 8, and    corresponds to apoptotic cells according to the same notation. After 
fitting of these individual specific mAb productivities it was observed that the model was able to predict 
all the state variables including mAb profile reasonably well. The predictions are shown in Figure 9.11 for 
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single medium-replacement experiment (SP15) and Figure 9.12 for double medium-replacement 
experiment (SP16). 
Simulation parameters suggest that that the highest mAb production rate was obtained by caspase-3 active 
cells (  ) (Appendix D). 
When compared predictive capability of the integrated model which included inhibitory effect with the 
integrated model which included effect of unknown nutrient, it was found that both the models predict the 
medium-replacement experiments almost similarly, although there was a difference found in SSE. The 
SSE was found somewhat lower in integrated model which included inhibitory effect „ ‟ than that with 
unknown nutrient effect „ ‟. The difference in SSE was around ~20%. However, Naderi et al., (2011) was 
found that for multiple partial medium-replacements, the cell maximum was progressively lower than the 
previous cell maximum following each medium-replacement event, which required the incorporation of 
the integration term in     to account for irreversible cell damage due to accumulation of CO2. 
 
 
Figure 9.11: Comparison of experimental observations with simulated profiles of cell subpopulations, 
glucose, metabolites and mAb in single medium-replacement experiment (SP14). The solid curves 




Figure 9.12: Comparison of experimental observations with simulated profiles of cell subpopulations, 
glucose, metabolites and mAb in double medium-replacement experiment (SP15). The solid curves 













Chapter 10  
Conclusions and recommendations 
The overall goal of this thesis was to model the evolution of growth and apoptosis in CHO cell culture 
and assess their impact on monoclonal antibody productivity. Different factors contributing to growth and 
apoptosis were identified and their effects were quantified using the model. Based on general available 
knowledge of apoptotic pathways, the main factors studied were nutrient depletion effects in media and/or 
serum and cell-cell interactions effects related to cell density.  The key novelty of this mathematical 
model is that it considers balances of both intracellular as well as extracellular species. Intracellular 
caspases were studied since they are good indicators of the active apoptotic pathways‟ occurring in 
process, e.g. caspase-8 is related to cell-cell interactions whereas caspase-9 levels are known to be related 
to either nutrient depletion or toxicants‟ levels. Furthermore, although mathematical models of 
intracellular species including caspases, have been proposed before in the literature (Eissing et al. 2004; 
Fussenegger et al. 2000; Spencer and Sorger, 2011), to the knowledge of the author these earlier reported 
models have never been verified by experimental data. In contrast, the current work proposes a novel 
population-balances‟ based model of caspases which has been calibrated and verified by flow cytometry 
measurements of caspases. Then, based on the identified model, the study suggests a direction towards a 
suitable operation of cell culture for maximized production of mAb.  
The following conclusions refer to the quality of the model and the factors that seem to affect growth 
arrest and apoptosis as quantified by combining the model with experimental observations. Also, 
conclusions are given regarding limitations in the analytical techniques used to collect data and the impact 




Model analysis: The original model was developed by considering a range of hypotheses (resulting in the 
24 model variants discussed in Chapter 5) regarding CHO cell culture. The model revealed that growth 
arrest is mostly correlated to the buildup of an inhibitor in the culture. Furthermore, the fact that cultures 
of different volumes resulted in significant differences in maximal cell density led to the hypothesis that 
growth arrest is related to the accumulation of a gas that is inhibitory for growth and results in significant 
deviation of pH from its optimal range, possibly due to carbon dioxide. The model variant that was 
selected provides good agreement with the experimental observations of various cell subpopulations. The 
model also served to test the sensitivity of the process to different factors affecting growth arrest and 
apoptosis. For instance, the model sensitivity and identifiability analysis (Chapter 5) shows that the 
parameter associated with cell density dependence has a strong effect on the model behavior, indicating 
the prominent effect of cell density on apoptosis. The possibility of cell density dependence could not be 
avoided as removing this dependency in the model did not provide good fitting and prediction of state 
variables in the model.  It is logical to assume that this significant dependence of the progression rate of 
apoptosis on cell density is related to cell-cell interactions (which were confirmed by preliminary Western 
blot measurements of FASL). Furthermore, the model shows that this interaction effect is mostly 
originating from caspase-3 active cells which initiate apoptotic signals further promoting apoptosis among 
healthy cells. The additional novel feature of the proposed model is that the population balances of 
intracellular caspases have been coupled to the evolution of the extracellular metabolites in the culture 
including nutrients and by-products. This coupling is essential if the model is to be used in the future for 
optimization since any optimal recipe will involve manipulation of extracellular culture conditions. The 
model of intracellular species categorizes the whole cell populations into different subpopulations based 
on caspase activity.  To the author‟s knowledge is the first ever effort towards modeling these two 
domains simultaneously. The coupling of balances of intracellular species and extracellular species 
provides more insight into cell culture behavior as compared to modeling the extracellular species only 
and thus it is expected to be more reliable for the purpose of process optimization. This comprehensive 
model is found to predict cell subpopulations, metabolites, nutrients and product reasonably well.  The 
analysis of the model shows the contribution to mAb production by different cell populations at different 
rates. The highest production rate appears to be contributed by capsase-3 active cells as shown in Chapter 
9. 
Sensitivity to cell density: Cell growth and apoptosis progression were found to be significantly affected 
by cell density. Though it was found from the volume experiment that inhibitory effects were the main 
trigger in affecting the cell growth, removing cell density dependence in simulation, led to inaccurate 
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predictions. Thus it was concluded that cell density has definitely an effect in addition to the observed 
inhibition effects related to culture volume. 
Sensitivity to serum: Experiments with different levels of serum in low cell density cultures showed 
enhanced growth especially above 1% levels (Chapter 6). Higher initial serum concentration above 1% 
offered higher specific growth rate, thus obtaining higher maximum cell concentration. The lower 
maximum cell concentration in lower serum level below 1% as compared that in higher serum level of 
2% in low cell density cultures can be attributed to the depletion of a nutrient (possibly some growth 
factor) present in serum. Whereas in higher initial cell density cultures, the similar maximum viable cell 
concentrations in different serum levels ranging from 0.5% to 4%,  can be attributed to toxicity due to 
rapid pH drop possibly due to CO2 accumulation because of high cell concentration. Higher specific 
growth rate resulted in higher specific mAb productivity. However, in Chapter 7, the correlation between 
productivity and growth was less conclusive since mAb productivity was found similar for different 
specific growth rate cultures (SP10-11). This may be attributed to the variability in ELISA method as 
described below and further studies are needed to investigate this correlation. Though different initial 
serum concentration for a given initial cell density did not have any effect on viability, it however 
affected apoptosis progression. For higher initial cell density, different levels of serum did not affect the 
progression of caspase-9 and caspase-3 (Chapter 6). However, for lower cell density, different levels of 
serum were found to have an effect on these caspases‟ cell populations. It can be hypothesized that for 
low levels of serum, some nutrient contained in the serum becomes depleted thus leading to lower cell 
growth and faster progression of apoptosis due to nutrient stress. 
Reversibility in cell growth inhibition: In medium-replacement experiments it was found that the cells 
could not revert to previous growth ability following each medium-replacement event. This can be 
attributed to the combination of two effects: i - after each medium-replacement event the cell density is 
progressively larger thus causing faster accumulation of the inhibitory compound and ii - after cells are 
exposed to critical levels of an environmental stress, e.g. exposure to high levels of CO2 accumulation, 
they cannot recover the ability to grow they had before that exposure. This acidic environment is 
detrimental to cell growth possibly due to DNA damage in cells which restricted cell growth and led to 
senescence or/and apoptosis thereafter. This was also observed in other studies (Jolly et al., 2004) where 
it was found that an acidic environment induced DNA damage. p53 is reported to regulate cell arrest in 
the G1/S checkpoint after DNA damage, however to the author‟s knowledge, there are no previous 
reports on whether DNA damaged cells revert to normal growth conditions after DNA repair by p53. As 
stated in the literature review, cells in G0/G1 (quiescent state) phase can remain in this state for an 
indefinite amount of time and can revert to normal conditions after suitable stimulation of environmental 
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conditions. On the other hand, the experimental measurements of caspases showed continued progression 
of percent caspase-active cells to the almost similar levels as those reached in the negative control culture 
(SP13) even after medium-replacements, supporting the hypothesis that the cells which have undergone 
DNA damage due to acidic environment may not have actually spent time in a growth arrest state 
(induced by p53) due to this damage, but switched to apoptosis more quickly. After the first medium-
replacement, metabolic activity of cells is increased due to favorable pH conditions and cell density. 
However within the cell population which were already exposed to critical CO2 levels from the earlier 
event (before medium- replacement) a large proportion of them switched to apoptosis, thus restricting the 
ability of cells in achieving the same cell concentration maxima as in the period before medium-
replacement was done. 
Sensitivity to culture volume: Cell behavior was found to be highly dependent on initial culture volume. 
Higher specific growth and higher maximum cell concentration were obtained with lower volume 
(Chapter 7). Thus, stoppage of growth seems to be correlated to the accumulation of a compound, 
possibly, CO2 which accumulates within the culture due to lower surface to volume ratio. Accumulation 
of this compound was accompanied by a drop in pH which possibly inhibited cell growth by cell cycle 
arrest possibly at the G1/S checkpoint. Partial or full medium-replacement of this culture with 
supplementation of fresh medium was used to reduce the effect of CO2 and thus pH. However, as 
observed in Chapter 9, although full medium-replacement could help in reviving cell growth to some 
extent, due to high cell density following each medium-replacement and subsequently high metabolic 
activity, the culture rapidly returned to undesirable conditions. Thus gradually the cells lost their ability 
for growth and the cell concentration maxima became lower after each medium-replacement event.  
Sensitivity to nutrients and metabolites: In this study glucose and glutamine, although they were not 
limiting, were found to be essential for cell growth.  The levels of glucose should not be too high so as to 
avoid high lactate concentration and osmolality, but should not be too low to avoid depletion that may 
initiate apoptotic cell death.  
Sensitivity to pH control: As seen in Chapter 9, pH control by base addition resulted in higher cell 
growth as compared to cultures where pH was not controlled. Levels of pH 7.1-7.2 were optimal for 
growth but control of pH by base addition resulted in markedly high glucose consumption rate and 
corresponding higher lactate production rate.  
Analytical methods: Although it was initially intended to measure the concentration of ligands such as 
FASL that mediate cell-cell communication related apoptosis, these measurements were not conclusive 
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due to background noise or nonspecific binding in the western blot technique used for that purpose. 
Signal to noise ratio in the western blot technique for measuring FASL activity can be improved by using 
CHO version of primary antibody, by manipulating blocking time and protein concentration loaded into 
gel and by optimizing the concentration of primary and secondary antibody. 
Recommendations and Future Work 
 Testing cell reversibility following exposure to non-optimal levels of pH or to glucose depletion 
conditions.  Irreversibility in cell growth inhibition was found to be important in medium- 
replacement experiments. This subject could be investigated through operation of continuous 
reactors and by correlating time of exposure to unfavorable conditions with irreversibilities. 
 Glucose resulted in high buildup of lactate which may be inhibitory. Thus, future work should 
investigate the use of other slower utilized carbon sources galactose or fructose, which 
considerably reduces formation of lactate. However, these carbon sources might result in slower 
cell growth because of slower utilization. Similarly glutamine concentration should be 
manipulated to avoid excessive buildup of ammonia. 
 The faster depletion of glucose in the pH controlled experiment was followed by very steep 
decrease in cell viability. Future work should study pH controlled fed-batch operation where 
glucose is fed continuously to avoid depletion while avoiding excessive lactate buildup or high 
osmolality.  
 The medium-replacement was found to be beneficial for growth and mAb productivity. It is 
suggested to investigate the implementation of an optimal schedule of medium-replacements to 
maximize productivity. The model developed in this work is an ideal tool to perform such 
optimization task.   
 The sensitivity of growth to volume also encourages implementation of monitoring CO2 levels for 
optimal process operation and implementation of strategies for its faster removal from a 
suspension culture. For industrial bioreactors, the requirement of large headspace or an open 
system with continuous flow of air becomes necessary. This should ensure that CO2 produced by 
cells satisfactorily diffuse from culture medium without accumulation and thus subsequence drop 
in pH. In laboratory reactors (spinner flasks), a simple approach could be leveling off the CO2 
level slowly inside the incubator before the cells reach the maximal density.  
 Since pH is an important factor in controlling cell growth, attention should be given to reduce the 
effect of pH. A way to reduce the effect of pH, is to use a medium of higher buffering capacity 









Derivatization reaction of PITC (phenylisothiocyanate) with amino acid forming PTC (phenylthiocarbamyl) (Butler 







Calculation of the specific depletion and production rates 
 




      
 
where   represents a nutrient/metabolite/product (glucose, lactate or mAb) concentration 
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The quantity    over the whole culture period was calculated from the slope of the plot of    vs. time 
integral of viable cells (   ), ∫   
 
 
  . The viable cell concentration being a continuous function, the 
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where   represents all the sample points 









Statistical test for    among serum level experiments  
 
 
A sample was generated by calculating instantaneous slopes of the plot of time integral of viable cells and 
mAb concentration (Figure 6.8) in each experiment SP5-8. The variability associated with these slopes 
corresponding to each experiment were compared each other by F-test. Following shows the results of the 
test at a significance level of 5%. 
  
 
            
SP5-SP6 3.11 9.27 (df2/df1-3/2) 
SP5-SP7 2.42 9.5 (df2/df1-3/2) 
SP5-SP8 1.10 9.5 (df2/df1-3/2) 
SP6-SP7 7.55 19 (df2/df1-2/2) 
SP6-SP8 2.82 19 (df2/df1-2/2) 








Parameter estimates of the integrated model  
Apoptosis Model  Metabolic Flux Model 
Parameter Value Parameter Value  Parameter Value Parameter Value 
   0.71     0.16     0.38     0.34 
   1.34  1.28     0.0003     1x10
-5
 
   0.05    0.07     0.0243     0.04 
      0.99     8.98     0.12     0.27 
   2.8     0.001     1.48     0.97 
   4.5     0.50     1.34 x 10
-5
      2.41 
   0.0013      0.09     0.071      0.509 
   5.13    0.001     0.024       4.968 
  0.03
 
    7.99     3.15      0.223 
    6.05    0.99      3.48      0.096 
    




    22.1      0.0605 
    

























    15.95 9416.05    0.103 0.31 
 7.69 2079.34     0.089 0.27 
   2.33 84.52     0.099 0.24 
   1.91 50.71     0.110 0.13 
   2.91 43.28     0.299 0.012 
   1.26 29.80    0.049 0.010 
   3.61 8.16     0.020 0.007 
   0.46 7.70   0.040 0.001 
   0.42 5.98     0.272 3.02E-05 
   0.419 5.62    0.0008 8.29E-06 
    0.413 5.48    0.109 7.11E-06 
   0.553 5.20     0.003 5.27E-06 
   0.975 2.69    0.001 2.49E-06 
   0.441 2.10     8.19E-05 5.73E-08 
    0.803 1.73    8.6E-05 2.41E-08 
    0.522 1.37    0.0004 8.83E-10 
   0.185 1.10     2E-05 3.36E-11 
     0.197 0.94     0.038 3.4E-12 





Titration curve  
The following observation indicates titration curve generated in 250 mL of culture in decline phase by 
addition of 1N NaOH (base) for adjusting pH in culture medium. Following observations were 
extrapolated for 500 mL culture volume. 
Volume of base 
added (µL) 
pH of culture after 
addition of base 
Total volume of base for a 
given pH value to reach (µL) 
0 6.54 0 
2 6.55 2 
5 6.55 7 
10 6.56 17 
20 6.57 37 
40 6.6 77 
50 6.63 127 
70 6.67 197 
90 6.73 287 
100 6.79 387 
100 6.84 487 
100 6.9 587 
100 6.96 687 
100 7.01 787 
100 7.06 887 
100 7.12 987 
100 7.17 1087 
100 7.23 1187 
100 7.27 1287 












y = 0.0006x + 6.5565 
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